http://cardiobrief.org/2010/09/09/lancet-meta-analysis-finds-high-risk-for-carotid-stenting-in-older-patients/2010-09-09T23:48:36+00:00monthlyhttp://cardiobrief.org/2010/09/09/medical-nonprofits-starting-to-disclose-revenue-from-industry/2010-09-09T20:34:06+00:00monthlyhttp://cardiobrief.org/2010/09/09/protective-effect-of-education-only-occurs-in-high-income-countries/2010-09-09T21:23:40+00:00monthlyhttp://cardiobrief.org/2010/09/07/patients-still-overestimate-benefits-of-elective-pci/2010-09-08T02:37:59+00:00monthlyhttp://cardiobrief.org/2010/09/07/bmj-papers-increase-pressure-on-avandia/2010-09-07T15:30:24+00:00monthlyhttp://cardiobrief.org/2010/08/27/the-debate-over-cme-and-industry-influence-continues/2010-09-07T15:38:27+00:00monthlyhttp://cardiobrief.org/2010/09/03/the-rise-of-the-esc-is-the-esc-anti-american-or-pro-industry/2010-09-05T21:07:47+00:00monthlyhttp://cardiobrief.org/2010/09/01/nejm-editors-call-for-removal-of-sibutramine-from-the-us-market/2010-09-09T10:55:28+00:00monthlyhttp://cardiobrief.org/2010/09/01/study-examines-long-term-effect-of-intensive-bp-control-in-blacks/2010-09-01T23:28:10+00:00monthlyhttp://cardiobrief.org/2010/09/01/double-dose-clopidogrel-gains-support-in-current-oasis-7/2010-09-01T23:24:37+00:00monthlyhttp://cardiobrief.org/2010/08/31/esc-apixaban-beats-aspirin-for-stroke-prevention-in-af/2010-08-31T20:14:46+00:00monthlyhttp://cardiobrief.org/2010/08/30/circulation-african-americans-at-higher-risk-for-stent-thrombosis/2010-08-31T17:48:41+00:00monthlyhttp://cardiobrief.org/2010/08/31/esc-positive-results-for-rivaroxaban-in-einstein-dvt/2010-08-31T08:17:25+00:00monthlyhttp://cardiobrief.org/2010/08/30/dronedarone-and-ticagrelor-speed-into-esc-guidelines/2010-08-30T13:02:29+00:00monthlyhttp://cardiobrief.org/2010/08/29/esc-superiority-of-dabigatran-more-evident-in-places-where-inr-is-not-well-controlled/2010-08-29T20:48:59+00:00monthlyhttp://cardiobrief.org/2010/08/29/esc-downshifting-heart-rate-in-hf-found-beneficial/2010-09-08T13:19:28+00:00monthlyhttp://cardiobrief.org/2010/08/29/esc-alpha-omega-trial-tests-n-3-fatty-acids-in-cv-disease/2010-08-29T20:46:02+00:00monthlyhttp://cardiobrief.org/2010/08/29/esc-genetic-substudies-of-large-trials-question-value-of-clopidogrel-genotyping/2010-08-29T20:42:37+00:00monthlyhttp://cardiobrief.org/2010/08/29/esc-hot-line-trial-turns-out-to-be-ice-cold/2010-08-29T17:13:52+00:00monthlyhttp://cardiobrief.org/2010/08/29/esc-responds-to-controversy-over-previous-publication-of-a-hot-line-trial/2010-08-29T17:12:12+00:00monthlyhttp://cardiobrief.org/2010/08/31/esc-no-benefits-for-low-dose-heparin-over-standard-heparin-in-futura-oasis-8/2010-08-29T01:14:14+00:00monthlyhttp://cardiobrief.org/2010/08/30/esc-4-year-findings-from-the-reach-registry/2010-08-29T01:11:05+00:00monthlyhttp://cardiobrief.org/2010/08/28/fda-approves-combination-of-aliskiren-and-amlodipine-for-treatment-of-hypertension/2010-08-29T00:58:38+00:00monthlyhttp://cardiobrief.org/2010/08/26/fda-sets-september-20-date-for-dabigatran-pradaxa-advisory-panel/2010-08-26T17:14:50+00:00monthlyhttp://cardiobrief.org/2010/08/26/i-guess-the-esc-is-really-happening/2010-08-26T16:30:13+00:00monthlyhttp://cardiobrief.org/2010/08/23/aha-late-breakers-ascend-hf-rocket-af-gravitas-gene-therapy-basket-prove-anacetrapib/2010-08-23T23:56:59+00:00monthlyhttp://cardiobrief.org/2010/08/23/cardiobrief-aha-science-advisory-calls-for-more-research-on-cvd-in-asian-americans/2010-08-23T20:57:33+00:00monthlyhttp://cardiobrief.org/2009/04/13/statins-may-have-caused-the-financial-breakdown-according-to-completely-unreliable-experts/2010-08-22T17:55:50+00:00monthlyhttp://cardiobrief.org/2010/08/20/gsk-letter-to-tide-investigators-provokes-avandia-critics/2010-08-20T14:16:08+00:00monthlyhttp://cardiobrief.org/2010/08/17/saving-time-and-setting-the-clock-back-in-ste/2010-08-18T01:30:08+00:00monthlyhttp://cardiobrief.org/2010/08/17/debating-medical-promotion-and-education/2010-08-17T15:24:00+00:00monthlyhttp://cardiobrief.org/2010/08/16/cardiobriefs-red-meat-antagonistic-people-and-chocolate/2010-08-16T22:18:31+00:00monthlyhttp://cardiobrief.org/2010/08/12/crescendo-one-last-aria-for-rimonabant/2010-08-12T23:27:08+00:00monthlyhttp://cardiobrief.org/2010/08/12/ajc-editorial-seriously-proposes-that-statins-be-offered-freely-at-fast-food-restaurants/2010-08-13T07:52:27+00:00monthlyhttp://cardiobrief.org/2010/08/11/shape-shifting-transforming-guidelines-into-a-business-venture/2010-08-11T16:04:24+00:00monthlyhttp://cardiobrief.org/2010/08/10/dallas-valve-meeting-withdraws-previous-statements-about-its-relationship-with%c2%a0theheart-org/2010-08-10T03:26:12+00:00monthlyhttp://cardiobrief.org/2010/08/09/shape-getting-ready-to-update-its-controversial-guidelines/2010-08-10T21:41:32+00:00monthlyhttp://cardiobrief.org/2010/08/06/fda-advisory-panel-will-review-meridia-sibutramine-on-september-15/2010-08-06T18:57:54+00:00monthlyhttp://cardiobrief.org/2010/08/04/at-the-dallas-valve-meeting-even-the-faculty-is-for-sale/2010-08-06T17:55:02+00:00monthlyhttp://cardiobrief.org/2010/08/03/medicines-company-wins-key-ruling-in-effort-to-extend-patent-on-bivalirudin/2010-08-03T21:35:39+00:00monthlyhttp://cardiobrief.org/2010/08/02/calcium-and-the-law-of-unintended-consequences/2010-08-02T17:33:22+00:00monthlyhttp://cardiobrief.org/2010/08/01/donald-shiley-valve-inventor-dead-at-90/2010-08-04T13:56:19+00:00monthlyhttp://cardiobrief.org/2010/07/30/a-missing-piece-of-the-multaq-puzzle-finally-appears-dionysos-published-to-little-fanfare/2010-07-30T21:07:21+00:00monthlyhttp://cardiobrief.org/2010/07/28/live-blogging-the-fda-brilinta-panel-afternoon-session/2010-07-28T21:13:27+00:00monthlyhttp://cardiobrief.org/2010/07/28/live-blogging-the-fda-brilinta-panel-morning-session/2010-07-28T16:50:23+00:00monthlyhttp://cardiobrief.org/2010/07/27/mixed-reviews-for-brilinta-prior-to-wednesdays-fda-panel/2010-07-27T15:42:03+00:00monthlyhttp://cardiobrief.org/2010/07/27/terry-ferguson-moves-to-astrazeneca/2010-07-27T14:30:10+00:00monthlyhttp://cardiobrief.org/2010/07/26/fda-finally-posts-briefing-documents-for-brilinta-ticagrelor-advisory-panel/2010-07-26T21:40:05+00:00monthlyhttp://cardiobrief.org/2010/07/26/dc-storm-causes-delay-in-release-of-brilinta-ticagrelor-briefing-materials/2010-07-28T15:36:49+00:00monthlyhttp://cardiobrief.org/2010/07/25/is-it-safe/2010-07-25T20:29:18+00:00monthlyhttp://cardiobrief.org/2010/07/23/fda-refers-avandia-panelist-conflict-of-interest-case-to-hhs-inspector-general/2010-07-24T00:52:13+00:00monthlyhttp://cardiobrief.org/2010/07/23/fda-approves-first-generic-low-molecular-weight-heparin/2010-07-23T23:39:44+00:00monthlyhttp://cardiobrief.org/2010/07/14/day-2-of-the-fda-avandia-panel-live-blogging-the-end/2010-07-21T23:29:56+00:00monthlyhttp://cardiobrief.org/2010/07/21/jupiter-hdl-doesnt-predict-residual-risk-in-statin-treated-patients-with-low-ldl-levels/2010-07-21T18:56:26+00:00monthlyhttp://cardiobrief.org/2010/07/21/fda-puts-tide-on-partial-clinical-hold/2010-07-21T16:54:25+00:00monthlyhttp://cardiobrief.org/2010/05/14/guest-post-shocking-revelations-at-the-hrs/2010-07-21T16:15:45+00:00monthlyhttp://cardiobrief.org/2010/05/24/guest-post-do-hundreds-of-left-atrial-burns-reduce-dementia-risk/2010-07-21T16:15:31+00:00monthlyhttp://cardiobrief.org/2010/07/21/guest-post-prophylactic-icds-may-not-benefit-women/2010-07-21T16:15:18+00:00monthlyhttp://cardiobrief.org/2010/07/20/2-avandia-panel-members-found-to-have-received-money-from-gsk-and-takeda/2010-07-20T21:49:24+00:00monthlyhttp://cardiobrief.org/2010/07/20/avandia-panel-member-received-speaking-fees-from-gsk/2010-07-20T20:57:22+00:00monthlyhttp://cardiobrief.org/about-2/2010-07-20T18:38:22+00:00weekly0.6http://cardiobrief.org/2010/07/16/avandia-aftermath-who-are-the-winners-and-losers/2010-07-16T16:26:25+00:00monthlyhttp://cardiobrief.org/2010/07/15/cleveland-clinic-retains-top-position-on-usnwr-list-of-top-heart-hospitalis/2010-07-16T03:38:00+00:00monthlyhttp://cardiobrief.org/2010/07/15/fda-announces-safety-review-of-arbs-and-cancer/2010-07-15T19:31:41+00:00monthlyhttp://cardiobrief.org/2010/07/14/dick-cheney-receives-an-lvad/2010-08-16T01:54:53+00:00monthlyhttp://cardiobrief.org/2010/07/14/gsk-issues-statement-in-response-to-fda-avandia-panel/2010-07-14T21:15:01+00:00monthlyhttp://cardiobrief.org/2010/07/14/day-2-of-the-fda-avandia-panel-live-blogging-the-morning/2010-07-14T16:03:32+00:00monthlyhttp://cardiobrief.org/2010/07/13/day-1-of-the-fda-avandia-panel-live-blogging/2010-07-14T13:46:41+00:00monthlyhttp://cardiobrief.org/2010/07/13/day-1-of-the-fda-avandia-panel-live-blogging-the-afternoon/2010-07-14T02:13:10+00:00monthlyhttp://cardiobrief.org/2010/07/13/ny-times-gsk-concealed-negative-avandia-study/2010-07-13T17:18:08+00:00monthlyhttp://cardiobrief.org/2010/07/12/effient-and-verifynow-a-match-made-in-heaven/2010-07-23T07:58:04+00:00monthlyhttp://cardiobrief.org/2010/07/12/handicapping-the-avandia-fda-panel/2010-07-12T19:47:05+00:00monthlyhttp://cardiobrief.org/2010/07/09/fda-posts-avandia-briefing-documents-ahead-of-next-weeks-advisory-panel-meeting/2010-07-11T19:23:50+00:00monthlyhttp://cardiobrief.org/2010/07/09/pioglitazone-beats-rosiglitazone-in-fda-review-of-controlled-epidemiologic-studies/2010-07-09T18:53:26+00:00monthlyhttp://cardiobrief.org/2010/07/09/5-different-ways-of-spinning-record/2010-07-09T16:56:01+00:00monthlyhttp://cardiobrief.org/2010/07/08/authors-of-jupiter-attack-committed-self-plagiarism/2010-07-23T23:47:36+00:00monthlyhttp://cardiobrief.org/2010/07/07/nejm-editors-were-not-fully-aware-of-gsk-and-merck-manipulation-of-avandia-and-vytorin-dsmbs/2010-07-07T22:32:24+00:00monthlyhttp://cardiobrief.org/2010/07/02/why-was-an-abbott-marketing-study-published-in-the-american-journal-of-cardiology-2/2010-07-07T16:06:39+00:00monthlyhttp://cardiobrief.org/2010/07/06/study-finds-no-benefit-for-tight-bp-control-in-diabetics-with-cad/2010-07-07T15:43:18+00:00monthlyhttp://cardiobrief.org/2010/07/01/trial-raises-concerns-over-cv-safety-of-testosterone-gel/2010-07-01T19:07:21+00:00monthlyhttp://cardiobrief.org/2010/06/30/prasugrel-critics-once-again-raise-cancer-concerns/2010-06-30T19:30:46+00:00monthlyhttp://cardiobrief.org/2010/06/29/accord-analyses-find-a-few-faint-glimmers-of-hope/2010-06-30T00:05:53+00:00monthlyhttp://cardiobrief.org/2010/06/29/authors-of-jupiter-attack-are-members-of-obscure-anti-cholesterol-group/2010-08-15T13:18:53+00:00monthlyhttp://cardiobrief.org/2010/06/28/meta-analysis-questions-value-of-statins-for-primary-prevention-jupiter-comes-under-attack/2010-07-02T14:15:26+00:00monthlyhttp://cardiobrief.org/2010/06/28/acc-and-aha-respond-to-boxed-warning-on-clopidogrel/2010-06-28T18:20:16+00:00monthlyhttp://cardiobrief.org/2010/06/28/tightening-the-noose-yet-again-on-avandia/2010-06-28T14:05:07+00:00monthlyhttp://cardiobrief.org/2010/06/26/once-weekly-exenatide-performs-well-in-duration-2/2010-06-25T22:01:54+00:00monthlyhttp://cardiobrief.org/2010/06/24/ada-kicks-off-with-lancet-papers-on-cv-deaths-in-diabetes-once-weekly-exenatide-and-dapagliflozin/2010-06-25T13:48:32+00:00monthlyhttp://cardiobrief.org/2010/06/25/chmp-recommends-european-approval-for-vernakalant-for-recent-onset-af/2010-06-25T13:26:09+00:00monthlyhttp://cardiobrief.org/2010/06/24/milwaukee-hospital-misreads-30-of-echocardiograms/2010-06-24T14:35:44+00:00monthlyhttp://cardiobrief.org/2010/06/23/accme-reverses-rule-that-would-have-prevented-industry-employees-from-speaking-at-scientific-sessions/2010-06-24T00:00:31+00:00monthlyhttp://cardiobrief.org/2010/06/23/cardiobriefs-eas-to-recommend-niacin-and-lpa-screening-lowering-homocysteine-fails-again/2010-06-24T03:20:26+00:00monthlyhttp://cardiobrief.org/2010/06/22/cardiobriefs-aggrenox-study-fails-livalo-launched-ny-times-spotlights-icds-with-benefits/2010-06-22T18:25:19+00:00monthlyhttp://cardiobrief.org/2010/06/21/cardiologist-accused-of-prescribing-unnecessary-icds-because-his-son-was-a-st-jude-salesman/2010-06-21T23:57:49+00:00monthlyhttp://cardiobrief.org/2010/06/19/what-do-outside-cardiologists-think-about-the-unread-echocardiograms-at-harlem-hospital/2010-06-21T00:53:47+00:00monthlyhttp://cardiobrief.org/2010/06/18/german-committee-recommends-against-reimbursement-for-avandia-and-actos/2010-06-18T19:47:01+00:00monthlyhttp://cardiobrief.org/2010/06/18/interstroke-accounting-for-stroke/2010-06-18T15:27:00+00:00monthlyhttp://cardiobrief.org/2010/06/18/new-delays-for-taspoglutide-renewed-cancer-concerns-for-insulin-glargine/2010-06-18T13:57:29+00:00monthlyhttp://cardiobrief.org/2010/06/17/trial-of-pfo-closure-fails-to-meet-primary-endpoint/2010-06-17T20:00:02+00:00monthlyhttp://cardiobrief.org/2010/06/16/industry-employees-no-longer-allowed-to-speak-at-aha-scientific-sessions/2010-06-16T22:13:51+00:00monthlyhttp://cardiobrief.org/2010/06/16/esc-posts-hot-line-trials-for-2010-congress-in-stockholm/2010-06-16T21:15:54+00:00monthlyhttp://cardiobrief.org/2010/06/16/cardiobriefs-new-generation-stent-tested-bms-versus-des-for-stemi/2010-06-16T20:05:20+00:00monthlyhttp://cardiobrief.org/2010/06/15/hdl-and-cancer-study-finds-strong-inverse-relationship/2010-06-15T15:41:34+00:00monthlyhttp://cardiobrief.org/2010/06/13/meta-analysis-finds-increased-risk-of-cancer-associated-with-arbs/2010-06-13T19:15:48+00:00monthlyhttp://cardiobrief.org/2010/06/11/fda-reviewing-safety-of-olmesartan-benicar/2010-07-11T23:20:41+00:00monthlyhttp://cardiobrief.org/2010/06/11/chicago-cardiologist-morton-arnsdorf-dies-in-car-crash/2010-06-11T13:32:32+00:00monthlyhttp://cardiobrief.org/2010/06/10/trial-comparing-apixaban-to-aspirin-in-af-stopped-for-efficacy/2010-06-10T22:56:48+00:00monthlyhttp://cardiobrief.org/2010/06/10/new-unpublished-study-may-help-tighten-the-noose-around-avandias-neck/2010-06-13T21:33:35+00:00monthlyhttp://cardiobrief.org/2010/06/09/cardiobriefs-mis-decline-over-past-decade-smoke-free-legislation-reduces-mi-admissions-in-england/2010-06-10T03:44:09+00:00monthlyhttp://cardiobrief.org/2010/06/08/atrial-fibrillation-a-big-messy-problem/2010-06-09T08:39:03+00:00monthlyhttp://cardiobrief.org/2010/06/04/fda-schedules-avandia-advisory-panel-for-july-13-14/2010-06-07T22:49:02+00:00monthlyhttp://cardiobrief.org/2010/06/06/investigators-in-maryland-expand-investigation-of-unnecessary-stenting/2010-06-06T21:02:42+00:00monthlyhttp://cardiobrief.org/2010/05/17/good-morning-american-segment-lands-some-hard-punches-on-the-aha/2010-06-05T13:07:44+00:00monthlyhttp://cardiobrief.org/2010/06/03/up-the-avandia-creek-without-a-paddle-canoe/2010-06-03T14:56:25+00:00monthlyhttp://cardiobrief.org/2010/06/02/fda-schedules-july-advisory-panel-for-brilinta-ticagrelor/2010-06-03T13:07:22+00:00monthlyhttp://cardiobrief.org/2010/06/02/listening-to-industry-whats-the-roi-of-medical-education/2010-08-27T15:45:11+00:00monthlyhttp://cardiobrief.org/2010/06/01/handicapping-the-july-fda-panel-on-avandia/2010-06-01T19:56:35+00:00monthlyhttp://cardiobrief.org/2010/05/31/can-we-trust-athena/2010-05-31T19:25:37+00:00monthlyhttp://cardiobrief.org/2010/05/29/at-least-200-patients-with-unread-echocardiograms-have-died/2010-05-29T23:36:26+00:00monthlyhttp://cardiobrief.org/2010/05/28/think-about-it-4000-echocardiograms-were-not-only-unread-but-unmissed/2010-05-29T13:40:54+00:00monthlyhttp://cardiobrief.org/2010/05/28/over-3-years-4000-echocardiograms-went-unread-at-nycs-harlem-hospital/2010-05-28T17:43:25+00:00monthlyhttp://cardiobrief.org/2010/05/28/even-more-people-may-have-received-unnecessary-stents-at-st-josephs/2010-05-28T17:10:29+00:00monthlyhttp://cardiobrief.org/2010/05/27/eplerenone-trial-stopped-early-after-reaching-its-primary-endpoint/2010-05-27T13:07:10+00:00monthlyhttp://cardiobrief.org/2009/03/11/statins-reduce-energy-and-interest-in-activty-new-study-suggests/2010-05-26T21:32:53+00:00monthlyhttp://cardiobrief.org/2010/05/26/guest-post-steve-nissen-and-jack-lewin-debate-interactions-with-industry/2010-05-26T18:11:57+00:00monthlyhttp://cardiobrief.org/2010/05/24/francis-collins-proposes-new-conflict-of-interest-rules-for-nih-funded-researchers-and-institutions/2010-05-24T14:41:22+00:00monthlyhttp://cardiobrief.org/2010/05/20/is-time-starting-to-run-out-for-tide-and-avandia/2010-05-20T04:39:33+00:00monthlyhttp://cardiobrief.org/2010/05/18/why-we-shouldnt-kill-all-the-lawyers-just-yet/2010-05-19T01:06:38+00:00monthlyhttp://cardiobrief.org/2010/05/07/vioxx-avandia-vytorin-absolute-risk-versus-relative-risk/2010-05-17T13:29:57+00:00monthlyhttp://cardiobrief.org/2010/05/14/guest-post-badness-in-baltimore-can-peer-review-catch-rogue-doctors/2010-05-14T21:25:26+00:00monthlyhttp://cardiobrief.org/2010/05/12/topol-vs-gurbel-experts-split-on-routine-genotyping-for-dapt/2010-05-13T14:06:31+00:00monthlyhttp://cardiobrief.org/2010/05/12/gust-bardy-answers-questions-about-the-entirely-subcutaneous-icd/2010-05-13T05:48:46+00:00monthlyhttp://cardiobrief.org/2010/05/10/lancet-meta-analysis-finds-some-benefits-for-fibrates/2010-05-10T20:38:26+00:00monthlyhttp://cardiobrief.org/2010/05/07/medtronic-tells-physicians-about-rare-software-issue-with-its-icds/2010-05-19T19:56:54+00:00monthlyhttp://cardiobrief.org/2010/05/05/hong-kong-authorities-issue-warning-about-medtronic-icds/2010-05-05T23:34:35+00:00monthlyhttp://cardiobrief.org/2010/05/05/stentapalooza-wednesday-spirit-iv-and-main-compare/2010-05-05T20:31:22+00:00monthlyhttp://cardiobrief.org/2010/05/04/the-wealth-gap-are-cardiologists-high-salaries-standing-in-the-way-of-primary-care/2010-05-04T20:38:55+00:00monthlyhttp://cardiobrief.org/2010/04/30/ehj-editors-rebuffed-gsk-efforts-to-suppress-nissen-editorial-on-rosiglitazone/2010-05-03T13:06:56+00:00monthlyhttp://cardiobrief.org/2010/04/30/the-survey-says-uphill-battle-for-effient-plavix-remains-strong-anticipation-grows-for-brillinta/2010-04-30T18:08:10+00:00monthlyhttp://cardiobrief.org/2010/04/29/tmi-personal-genome-used-in-clinical-assessment/2010-04-29T20:49:54+00:00monthlyhttp://cardiobrief.org/2010/04/29/roche-announces-more-positive-results-for-taspoglutide/2010-04-29T13:21:34+00:00monthlyhttp://cardiobrief.org/2010/04/28/vitamin-b-and-steroids-monuments-to-human-folly/2010-04-30T23:34:22+00:00monthlyhttp://cardiobrief.org/2010/04/27/us-judge-rejects-guidant-296-million-plea-agreement/2010-04-28T00:16:44+00:00monthlyhttp://cardiobrief.org/2010/04/27/calcium-screening-another-positive-study-another-critical-editorial/2010-04-27T19:27:35+00:00monthlyhttp://cardiobrief.org/2010/04/26/ppis-and-clopidogrel-new-study-finds-evidence-that-pantoprazole-may-also-be-a-problem/2010-04-26T20:01:35+00:00monthlyhttp://cardiobrief.org/2010/04/22/guest-post-medical-societies-new-ethics-code-secret-qa-document-revealed/2010-04-22T19:38:51+00:00monthlyhttp://cardiobrief.org/2010/04/21/guest-post-the-long-afterlife-of-joshua-oukrop/2010-04-21T18:48:22+00:00monthlyhttp://cardiobrief.org/2010/04/20/iom-report-heralds-new-fda-initiative-to-gradually-cut-salt-in-processed-foods/2010-04-20T18:51:49+00:00monthlyhttp://cardiobrief.org/2010/04/20/small-steps-lead-to-big-reduction-in-risk-for-overweight-mayo-clinic-cardiologist/2010-04-20T14:10:43+00:00monthlyhttp://cardiobrief.org/2010/04/18/residual-risk-reduction-initiative-promotion-or-education/2010-04-19T01:16:03+00:00monthlyhttp://cardiobrief.org/2010/04/15/boston-scientific-resumes-sales-of-cognis-and-teligen-icds/2010-04-16T00:34:04+00:00monthlyhttp://cardiobrief.org/2010/04/15/even-more-questions-about-multaq-and-prystowsky-alas/2010-04-16T21:19:16+00:00monthlyhttp://cardiobrief.org/2010/04/14/final-results-of-arbiter-6-halts-confirm-cimt-benefit-with-niacin-and-no-benefit-with-ezetimibe/2010-04-14T16:50:01+00:00monthlyhttp://cardiobrief.org/2010/04/13/promising-early-results-for-valve-in-valve-approach-to-failing-bioprosthetic-valves/2010-04-13T16:24:01+00:00monthlyhttp://cardiobrief.org/2010/04/12/guest-post-running-on-empty/2010-04-12T19:19:58+00:00monthlyhttp://cardiobrief.org/2010/04/11/nejm-trials-find-few-long-term-benefits-for-endovascular-aaa-repair/2010-04-10T18:44:17+00:00monthlyhttp://cardiobrief.org/2010/04/08/more-pieces-of-the-multaq-puzzle/2010-04-09T11:13:15+00:00monthlyhttp://cardiobrief.org/2010/04/07/survival-after-cabg-isn%e2%80%99t-about-skin-color-or-gender-it%e2%80%99s-about-being-poor/2010-04-07T22:25:01+00:00monthlyhttp://cardiobrief.org/2010/04/06/guest-post-the-ipad-goes-live-at-bidmc-2/2010-04-07T12:46:11+00:00monthlyhttp://cardiobrief.org/2010/04/06/experts-disagree-on-when-to-use-dronedarone-multaq/2010-04-06T19:40:40+00:00monthlyhttp://cardiobrief.org/2010/04/05/waiting-for-improve-it/2010-04-05T21:04:12+00:00monthlyhttp://cardiobrief.org/2010/03/31/prystowsky-lectures-resurfaces-this-time-with-coi-disclosures/2010-03-31T21:38:58+00:00monthlyhttp://cardiobrief.org/2010/03/26/more-multaq-prystowsky-whack-a-mole-acc-responds-sanofi-overtures-to-eps/2010-03-31T20:22:35+00:00monthlyhttp://cardiobrief.org/2010/03/25/pieces-of-a-puzzle-multaq-sanofi-acc-hrs-prystowsky-af-guidelines/2010-03-31T18:44:21+00:00monthlyhttp://cardiobrief.org/2010/03/31/new-york-times-broader-indication-for-rosuvastatin-once-again-raises-risk-vs-benefit-in-healthy-population/2010-04-01T14:32:42+00:00monthlyhttp://cardiobrief.org/2010/03/30/sec-and-doj-looking-into-boston-scientific-icd-recall/2010-04-04T16:59:08+00:00monthlyhttp://cardiobrief.org/2010/03/30/uks-nice-plays-a-bit-nicer-with-multaq-dronedarone/2010-03-30T17:29:17+00:00monthlyhttp://cardiobrief.org/2010/03/30/fda-delays-approval-of-certriad-rosuvastatinfenofibric-acid-combo/2010-03-30T16:34:53+00:00monthlyhttp://cardiobrief.org/2010/03/29/archimedes-the-computer-model-not-the-greek-supports-screening-for-diabetes/2010-03-29T21:31:47+00:00monthlyhttp://cardiobrief.org/2010/03/27/ny-times-most-nitroglycerin-in-the-us-is-in-regulatory-limbo/2010-03-27T23:22:56+00:00monthlyhttp://cardiobrief.org/2010/03/26/wtf-now-you-can-diagnose-your-own-heart-attack-right-at-home/2010-03-26T20:50:02+00:00monthlyhttp://cardiobrief.org/2010/03/23/avandia-again-nissen-and-jama-editors-spin-record-round-and-round/2010-03-23T22:03:37+00:00monthlyhttp://cardiobrief.org/2010/03/22/why-is-there-a-red-dress-on-diet-coke-cans/2010-03-26T23:41:54+00:00monthlyhttp://cardiobrief.org/2010/03/22/james-black-nobel-laureate-who-invented-beta-blockers-dead-at-85/2010-03-22T19:32:48+00:00monthlyhttp://cardiobrief.org/2010/03/20/fda-panel-recommends-approval-of-medtronics-mri-safe-pacemaker/2010-03-20T18:20:01+00:00monthlyhttp://cardiobrief.org/2010/03/19/fda-warns-about-increased-risk-of-myopathy-with-80-mg-simvastatin/2010-03-19T15:38:34+00:00monthlyhttp://cardiobrief.org/2010/03/18/fda-panel-supports-expanded-indication-for-crt-ds/2010-03-19T02:45:17+00:00monthlyhttp://cardiobrief.org/2010/03/18/fda-watchman-device-will-need-to-wait-a-bit-longer/2010-03-18T21:35:16+00:00monthlyhttp://cardiobrief.org/2010/03/18/more-details-emerge-about-boston-scientifics-suspension-of-icd-sales/2010-03-18T19:35:29+00:00monthlyhttp://cardiobrief.org/2010/03/18/guest-post-freezing-in-af-ablation-not-so-fast-you-all/2010-03-18T18:08:49+00:00monthlyhttp://cardiobrief.org/2010/03/17/fda-panel-set-to-review-expanded-indication-for-crt-d-and-first-mri-safe-pacing-system-new-mri/2010-03-17T17:45:19+00:00monthlyhttp://cardiobrief.org/2010/03/17/ahaacc-release-thoracic-aortic-disease-guidelines/2010-08-21T07:46:25+00:00monthlyhttp://cardiobrief.org/2010/03/16/cabg-in-platos-cave-is-the-reduction-in-mortality-real-or-an-illusion/2010-03-16T19:50:44+00:00monthlyhttp://cardiobrief.org/2010/03/15/us-attorneys-office-investigating-medtronic-over-ties-to-lahey-clinic-cardiologists/2010-03-15T17:38:50+00:00monthlyhttp://cardiobrief.org/2010/03/15/fda-says-it-will-review-the-accord-data/2010-03-15T17:00:01+00:00monthlyhttp://cardiobrief.org/2010/03/13/the-countdown-begins/2010-03-15T15:50:02+00:00monthlyhttp://cardiobrief.org/2010/03/15/sort-out-iii-chucks-out-zotarolimus-eluting-stents/2010-03-15T15:55:57+00:00monthlyhttp://cardiobrief.org/2010/03/15/boston-scientific-reportedly-suspends-icd-sales-due-to-administrative-errors/2010-03-15T14:22:43+00:00monthlyhttp://cardiobrief.org/2010/03/14/navigator-provides-little-guidance-in-diabetes/2010-03-14T19:19:38+00:00monthlyhttp://cardiobrief.org/2010/03/14/everest-ii-catheter-based-mitral-repair-system-reaches-new-peak/2010-03-14T19:13:39+00:00monthlyhttp://cardiobrief.org/2010/03/15/optimal-duration-of-dual-antiplatelet-therapy-still-unresolved/2010-03-14T17:30:22+00:00monthlyhttp://cardiobrief.org/2010/03/15/race-ii-dont-rush-to-slow-down/2010-03-14T15:45:58+00:00monthlyhttp://cardiobrief.org/2010/03/14/accord-fails-to-find-benefits-for-fenofibrate-or-lower-blood-pressure-target/2010-03-14T15:36:11+00:00monthlyhttp://cardiobrief.org/2010/03/13/acc-duke-study-links-stock-market-to-cardiac-events/2010-03-13T16:26:03+00:00monthlyhttp://cardiobrief.org/2010/03/12/plavix-label-gets-black-box-warning-about-poor-metabolizers/2010-03-12T23:33:20+00:00monthlyhttp://cardiobrief.org/2010/03/13/mipomersen-cuts-ldl-by-25-in-homozygous-fh-but-safety-concerns-remain/2010-03-12T00:31:55+00:00monthlyhttp://cardiobrief.org/2010/03/11/landslide-of-lancet-papers-suggest-importance-of-blood-pressure-variability/2010-03-12T00:10:24+00:00monthlyhttp://cardiobrief.org/2010/03/10/nejm-study-finds-low-diagnostic-yield-for-coronary-angiography/2010-03-10T22:13:56+00:00monthlyhttp://cardiobrief.org/2010/03/08/redberg-critical-of-obamas-coronary-calcium-scan/2010-03-09T00:34:07+00:00monthlyhttp://cardiobrief.org/2010/02/08/study-finds-significant-lesions-in-one-fifth-of-patients-with-zero-calcium-scores/2010-03-09T00:30:01+00:00monthlyhttp://cardiobrief.org/2010/03/08/calcium-scans-do-they-now-come-with-a-warranty/2010-03-08T20:41:40+00:00monthlyhttp://cardiobrief.org/2010/03/04/advance-2-apixaban-study-published-in-lancet/2010-03-04T18:48:27+00:00monthlyhttp://cardiobrief.org/2010/03/04/guest-post-sanjay-kaul-answers-questions-about-rosiglitazone/2010-03-04T13:47:04+00:00monthlyhttp://cardiobrief.org/2010/03/02/icd-implantation-may-cause-cognitive-problems-small-study-suggests/2010-03-26T03:30:40+00:00monthlyhttp://cardiobrief.org/2010/03/01/screening-young-athletes-to-ecg-or-not-to-ecg/2010-03-01T21:32:15+00:00monthlyhttp://cardiobrief.org/2009/02/17/new-data-on-sudden-death-in-young-athletes-published/2010-03-01T19:44:52+00:00monthlyhttp://cardiobrief.org/2010/02/26/crest-finds-carotid-stenting-broadly-equivalent-to-endarterectomy/2010-02-26T16:42:17+00:00monthlyhttp://cardiobrief.org/2010/02/25/carotid-endarterectomy-beats-stenting-in-first-results-from-icss/2010-02-25T23:50:12+00:00monthlyhttp://cardiobrief.org/2010/02/24/avandia-a-plaque-on-both-your-houses/2010-05-01T02:01:15+00:00monthlyhttp://cardiobrief.org/2010/02/23/jama-study-questions-value-of-platelet-function-tests-in-pci-patients/2010-02-23T23:27:08+00:00monthlyhttp://cardiobrief.org/2010/02/22/more-avandia-action-nissen-recorded-gsk-execs-fda-announces-safety-review/2010-02-23T02:47:10+00:00monthlyhttp://cardiobrief.org/2010/02/20/senate-releases-avandia-report-gsk-responds-to-attacks/2010-02-20T20:32:14+00:00monthlyhttp://cardiobrief.org/2010/02/20/ny-times-fda-and-senate-reports-slam-continued-availability-of-avandia-rosiglitazone/2010-02-20T05:21:32+00:00monthlyhttp://cardiobrief.org/2010/02/22/study-finds-increased-rate-of-stent-thrombosis-in-primary-pci-patients-who-get-distal-protection/2010-02-19T22:59:38+00:00monthlyhttp://cardiobrief.org/2010/02/17/accomplish-amlodopine-may-or-may-not-be-better-than-hydrochlorothiazide-in-combo-with-benazepril-to-slow-progression-of-kidney-disease/2010-02-18T00:13:15+00:00monthlyhttp://cardiobrief.org/2010/02/16/lancet-large-meta-analysis-confirms-small-increase-in-diabetes-with-statins/2010-02-17T22:44:40+00:00monthlyhttp://cardiobrief.org/2010/02/17/arts-ii-at-5-years-what-have-we-learned/2010-02-17T20:43:24+00:00monthlyhttp://cardiobrief.org/2010/02/16/jama-studies-find-little-evidence-to-support-genetic-testing-to-improve-cv-risk-assessment/2010-02-16T21:04:44+00:00monthlyhttp://cardiobrief.org/2010/02/12/boston-scientific-ceo-were-the-reports-of-icd-flaws-tied-to-attempts-to-drive-down-the-stock-price/2010-02-13T21:54:40+00:00monthlyhttp://cardiobrief.org/2010/02/11/roche-announces-more-positive-results-for-taspoglutide-but/2010-02-11T19:55:29+00:00monthlyhttp://cardiobrief.org/2009/12/02/roches-taspoglutide-beats-sitagliptin-in-phase-iii-trial/2010-02-11T19:35:16+00:00monthlyhttp://cardiobrief.org/2010/02/10/boston-scientific-and-william-maisel-clash-over-icd-flaws/2010-02-11T03:53:28+00:00monthlyhttp://cardiobrief.org/2010/02/08/rosuvastatin-crestor-gains-expanded-primary-prevention-indication/2010-06-16T04:11:15+00:00monthlyhttp://cardiobrief.org/2010/02/08/new-concerns-raised-about-boston-scientific-icds/2010-02-08T23:48:28+00:00monthlyhttp://cardiobrief.org/2010/02/06/the-two-sides-of-aspirin-too-much-and-not-enough/2010-02-06T20:17:26+00:00monthlyhttp://cardiobrief.org/2010/02/05/more-adverse-events-seen-in-patients-on-ppis-after-des/2010-02-05T22:11:04+00:00monthlyhttp://cardiobrief.org/2010/02/02/live-af-ablation-broadcast-on-today-show-whats-wrong-with-this-picture/2010-03-12T04:46:50+00:00monthlyhttp://cardiobrief.org/2010/02/02/alderman-in-jama-universal-sodium-reductions-are-a-rash-route/2010-02-03T01:23:15+00:00monthlyhttp://cardiobrief.org/2010/02/01/boston-scientific-pays-1-725-to-jj-to-settle-three-patent-disputes-over-stents/2010-02-01T20:20:23+00:00monthlyhttp://cardiobrief.org/2010/01/29/guest-post-chantix-and-cardiovascular-risk-another-weak-safety-study/2010-02-10T23:33:23+00:00monthlyhttp://cardiobrief.org/2010/01/28/lilly-reports-modest-sales-figures-for-effient-prasugrel/2010-01-28T17:33:26+00:00monthlyhttp://cardiobrief.org/2010/01/28/acc-10-i2-summit-in-atlanta-late-breaking-clinical-trials/2010-01-28T00:34:45+00:00monthlyhttp://cardiobrief.org/2010/01/27/study-identifies-shortcut-to-diagnosing-long-qt-syndrome/2010-01-27T18:33:52+00:00monthlyhttp://cardiobrief.org/2010/01/26/cath-lab-coming-attractions-3d-images-of-the-coronary-arteries/2010-01-27T13:18:28+00:00monthlyhttp://cardiobrief.org/2010/01/26/lancet-researchers-find-goldilocks-effect-in-glucose-control-for-diabetes/2010-01-26T19:48:40+00:00monthlyhttp://cardiobrief.org/2010/01/25/fda-approves-liraglutide-victoza-for-type-2-diabetes/2010-01-26T15:32:14+00:00monthlyhttp://cardiobrief.org/2010/01/26/jama-rf-ablation-superior-to-drugs-in-multicenter-af-trial/2010-01-26T15:25:33+00:00monthlyhttp://cardiobrief.org/2010/01/25/fda-approves-first-percutaneous-heart-valve-medtronics-melody-pulmonary-valve/2010-03-15T21:51:35+00:00monthlyhttp://cardiobrief.org/2010/01/21/generic-clopidogrel-besilate-makes-inroads-into-european-plavix-market/2010-01-22T19:38:19+00:00monthlyhttp://cardiobrief.org/2010/01/22/sandoz-starts-to-prepare-for-generic-enoxaparin-in-the-us/2010-01-22T18:46:01+00:00monthlyhttp://cardiobrief.org/2010/01/20/nejm-study-and-editorial-advocate-widespread-salt-reductions/2010-01-22T17:21:03+00:00monthlyhttp://cardiobrief.org/2010/01/21/european-medicines-agency-recommends-suspension-of-sibutramine/2010-01-21T22:55:49+00:00monthlyhttp://cardiobrief.org/2010/01/21/fda-sibutramine-now-contraindicated-in-people-with-cardiovascular-disease/2010-01-21T17:54:23+00:00monthlyhttp://cardiobrief.org/2010/01/20/nih-puts-baylor-on-a-tight-leash-after-failing-to-disclose-merck-payments-to-ballantyne/2010-01-21T13:44:10+00:00monthlyhttp://cardiobrief.org/2010/01/20/heartmate-ii-lvas-gains-destination-therapy-indication/2010-01-20T18:09:13+00:00monthlyhttp://cardiobrief.org/2009/11/17/aha-58-survival-rate-at-2-years-with-heartmate-ii-continuous-flow-lvad/2010-01-20T18:05:13+00:00monthlyhttp://cardiobrief.org/2010/01/19/study-suggests-fixed-doses-of-statins-may-be-better-than-treating-to-target/2010-01-19T19:37:51+00:00monthlyhttp://cardiobrief.org/2010/01/15/maryland-hospital-tells-hundreds-of-heart-patients-their-stents-may-have-been-unnecessary/2010-01-16T02:10:38+00:00monthlyhttp://cardiobrief.org/2010/01/13/the-introduction-of-ticagrelor-a-more-potent-and-effective-agent-which-is-as-safe-as-its-predecessor-is-a-landmark-event-that-should-redefine-the-care-of-patients-with-acute-coronary-syndromes/2010-01-14T20:28:34+00:00monthlyhttp://cardiobrief.org/2010/01/14/new-research-links-radiation-exposure-to-cv-disease/2010-01-14T20:23:01+00:00monthlyhttp://cardiobrief.org/2010/01/13/judge-rejects-acc-lawsuit-against-hhs-secretary-sebelius-over-medicare-cuts/2010-01-14T04:28:04+00:00monthlyhttp://cardiobrief.org/2010/01/13/syntax-have-drug-eluting-stents-removed-the-death-penalty-associated-with-diabetes-and-multivessel-pci/2010-01-13T20:25:03+00:00monthlyhttp://cardiobrief.org/2010/01/12/cocaine-plays-role-in-3-of-sudden-deaths-in-spain/2010-01-12T22:09:23+00:00monthlyhttp://cardiobrief.org/2010/01/12/increasing-adherence-to-statins-would-save-twice-the-number-of-lives-as-expanding-eligibility/2010-01-12T19:15:42+00:00monthlyhttp://cardiobrief.org/2010/01/11/fdas-cardiorenal-panel-unanimously-rejects-nebivolol-for-hf/2010-01-11T22:43:46+00:00monthlyhttp://cardiobrief.org/2010/01/11/archives-not-all-guidelines-are-created-equal/2010-01-11T19:35:34+00:00monthlyhttp://cardiobrief.org/2010/01/08/reevaluating-esas-too-little-too-late/2010-01-08T22:35:38+00:00monthlyhttp://cardiobrief.org/2010/01/07/compare-investigators-in-the-lancet-paclitaxel-eluting-stents-should-no-longer-be-used-in-everyday-clinical-practice/2010-01-08T16:40:05+00:00monthlyhttp://cardiobrief.org/2010/01/08/completion-of-improve-it-now-delayed-until-june-2013/2010-01-08T15:19:47+00:00monthlyhttp://cardiobrief.org/2010/01/07/note-to-readers-cardiobrief-editor-to-join-forces-with-nejms-cardioexchange/2010-01-07T22:46:47+00:00monthlyhttp://cardiobrief.org/2010/01/07/fda-staff-recommends-against-heart-failure-indication-for-bystolic-nebivolol/2010-01-07T18:29:36+00:00monthlyhttp://cardiobrief.org/2010/01/06/nejm-fda-to-reevaluate-esas-in-treatment-of-anemia/2010-01-06T20:21:25+00:00monthlyhttp://cardiobrief.org/2010/01/04/braunwald-in-all-fairness-what-was-ok-three-years-ago-is-not-ok-now-%e2%80%9d/2010-01-05T13:48:14+00:00monthlyhttp://cardiobrief.org/2009/12/31/leading-israeli-cardiologists-blocking-their-countrys-participation-in-planned-nih-funded-ischemia-trial/2009-12-31T19:33:20+00:00monthlyhttp://cardiobrief.org/2009/12/30/ictus-at-5-years-still-fails-to-find-benefit-for-early-invasive-strategy-in-acs/2009-12-30T20:22:23+00:00monthlyhttp://cardiobrief.org/2009/12/29/second-study-on-approval-of-cv-devices-largely-confirms-fda-deficiencies/2009-12-30T01:38:47+00:00monthlyhttp://cardiobrief.org/2009/12/29/jama-review-finds-lack-of-rigor-in-fda-approval-of-cv-devices/2009-12-29T22:24:59+00:00monthlyhttp://cardiobrief.org/2009/12/29/acc-files-lawsuit-against-hhs-secretary-sebelius-over-medicare-cuts/2009-12-29T20:31:27+00:00monthlyhttp://cardiobrief.org/2009/12/28/ahj-editorial-calls-for-something-equivalent-to-fluoride-in-the-drinking-water-to-fight-scd/2009-12-28T23:59:48+00:00monthlyhttp://cardiobrief.org/2009/12/24/study-finds-sprint-fidelis-lead-fractures-increasing-exponentially/2009-12-24T16:09:58+00:00monthlyhttp://cardiobrief.org/2009/12/21/lancet-huge-metaanalysis-finds-no-causative-role-of-crp/2009-12-23T23:54:46+00:00monthlyhttp://cardiobrief.org/2009/12/23/nejm-1-in-6-persons-have-lpa-variant-associated-with-increased-cad-risk/2009-12-23T16:12:15+00:00monthlyhttp://cardiobrief.org/2009/12/22/medicines-company-buys-apoa-1-milano-from-pfizer/2009-12-23T15:51:53+00:00monthlyhttp://cardiobrief.org/2009/12/22/genes-stem-cells-ticagrelor-and-dabigatran-among-ahas-top-10-for-2009/2009-12-22T18:43:50+00:00monthlyhttp://cardiobrief.org/2009/12/22/fda-says-cancer-risk-of-vytorin-and-zetia-is-unlikely/2009-12-30T23:27:33+00:00monthlyhttp://cardiobrief.org/2009/12/21/niacin-helps-restore-hdl-protective-effects-in-diabetics/2009-12-22T01:49:34+00:00monthlyhttp://cardiobrief.org/2009/12/18/primary-pci-without-surgical-backup-deemed-safe-in-nys-study/2009-12-18T15:21:29+00:00monthlyhttp://cardiobrief.org/2009/12/17/cardiome-says-vernakalant-bests-amiodarone-in-acute-conversion-of-af/2009-12-18T00:04:14+00:00monthlyhttp://cardiobrief.org/2009/12/17/aha-cv-disease-will-cost-500-billion-in-2010/2009-12-17T19:58:39+00:00monthlyhttp://cardiobrief.org/2009/12/17/roche-announces-positive-results-for-2-more-taspoglutide-trials/2010-02-18T19:15:39+00:00monthlyhttp://cardiobrief.org/2009/12/16/tcfa-the-most-relevant-form-of-human-disease-in-the-history-of-mankind/2009-12-16T21:38:40+00:00monthlyhttp://cardiobrief.org/2009/12/10/lancet-bleeding-risk-in-mi-patients-increases-with-dual-and-triple-therapy/2009-12-16T17:33:41+00:00monthlyhttp://cardiobrief.org/2009/12/15/fda-advisory-panel-backs-expanded-indication-for-crestor-rosuvastatin/2009-12-15T23:44:40+00:00monthlyhttp://cardiobrief.org/2009/12/15/review-finds-no-consistent-or-reproducible-treatment-effect-of-serial-calcium-scans/2009-12-30T23:24:40+00:00monthlyhttp://cardiobrief.org/2009/12/14/are-ct-scans-the-wild-west-of-todays-medicine/2009-12-15T17:57:38+00:00monthlyhttp://cardiobrief.org/2009/12/11/fda-sets-stage-for-tuesdays-crestor-rosuvastatin-advisory-panel/2009-12-11T22:30:24+00:00monthlyhttp://cardiobrief.org/2009/12/10/wired-david-eddys-efforts-to-replace-human-trials-with-computer-models/2009-12-10T18:34:55+00:00monthlyhttp://cardiobrief.org/2009/12/09/medtronic-cardiac-rhythm-device-unit-under-investigation-in-california/2009-12-09T23:28:33+00:00monthlyhttp://cardiobrief.org/2009/12/09/gao-fda-fails-to-make-adequate-changes-in-drug-safety-monitoring/2009-12-09T20:32:34+00:00monthlyhttp://cardiobrief.org/2009/12/08/many-dialysis-patients-undergoing-pci-receive-contraindicated-antithrombotics/2009-12-08T00:38:59+00:00monthlyhttp://cardiobrief.org/2009/12/08/new-mri-technique-uncovers-differences-in-mens-and-womens-hearts/2009-12-08T00:15:52+00:00monthlyhttp://cardiobrief.org/2009/12/07/cardiorenal-advisory-panel-to-take-up-nebivolol-for-heart-failure-in-january/2009-12-07T16:10:23+00:00monthlyhttp://cardiobrief.org/2009/12/06/rivaroxaban-einstein-at-ash-and-another-rock-on-the-road-to-approval/2009-12-09T17:51:49+00:00monthlyhttp://cardiobrief.org/2009/12/06/re-cover-at-ash-dabigatran-equals-warfarin-for-vte-treatment/2009-12-06T17:41:21+00:00monthlyhttp://cardiobrief.org/2009/12/05/industry-academic-researchers-and-clinical-trials-the-slippery-slope/2009-12-04T22:27:01+00:00monthlyhttp://cardiobrief.org/2009/11/20/einstein-at-ash-rivaroxaban-xarelto-prevents-recurrent-vte-but-bleeding-may-be-a-concern/2009-12-04T18:01:23+00:00monthlyhttp://cardiobrief.org/2009/12/04/bmj-risk-of-vte-after-surgery-is-higher-and-lasts-longer-than-expected/2009-12-04T15:13:45+00:00monthlyhttp://cardiobrief.org/2009/12/03/bmj-large-observational-study-finds-excess-cv-risk-for-sulphonylureas-but-benign-outcomes-for-tzds/2009-12-03T23:56:20+00:00monthlyhttp://cardiobrief.org/2009/12/03/us-justice-dept-weighing-criminal-charges-against-jj-over-natrecor-marketing/2009-12-03T18:25:49+00:00monthlyhttp://cardiobrief.org/2009/12/01/ama-its-hard-to-beat-the-framingham-risk-score/2009-12-01T20:00:55+00:00monthlyhttp://cardiobrief.org/2009/12/01/susan-shurin-to-serve-as-acting-director-of-nhlbi/2009-12-01T13:37:42+00:00monthlyhttp://cardiobrief.org/2009/11/30/circulation-exercise-may-help-slow-aging-process-by-protecting-telomeres/2009-11-30T21:06:19+00:00monthlyhttp://cardiobrief.org/2009/11/30/dronedarone-multaq-gains-eu-approval-for-atrial-fibrillation/2009-11-30T13:51:13+00:00monthlyhttp://cardiobrief.org/2009/11/25/nejm-very-low-troponin-t-levels-in-stable-cad-associated-with-death-and-hf-but-not-mi/2009-11-25T19:18:33+00:00monthlyhttp://cardiobrief.org/2009/11/24/report-new-niacin-scrips-rise-41-in-week-following-arbiter-6/2009-11-24T22:41:55+00:00monthlyhttp://cardiobrief.org/2009/11/24/jama-high-primary-pci-volume-doesnt-translate-into-lower-mortality/2009-11-24T18:38:57+00:00monthlyhttp://cardiobrief.org/2009/11/23/did-medicaid-pay-for-all-those-plavix-ads-on-the-news/2009-11-23T22:38:44+00:00monthlyhttp://cardiobrief.org/2009/11/23/vioxx-what-did-merck-know-and-when-did-it-know-it/2009-11-23T22:12:46+00:00monthlyhttp://cardiobrief.org/2009/11/22/one-week-later-the-arbiter-6-aftermath/2009-11-22T22:16:52+00:00monthlyhttp://cardiobrief.org/2009/11/20/fda-also-announces-safety-review-of-sibutramine-meridia/2009-12-07T16:54:19+00:00monthlyhttp://cardiobrief.org/2009/11/20/emea-investigating-increased-cardiovascular-risk-with-sibutramine/2010-02-10T00:45:40+00:00monthlyhttp://cardiobrief.org/2009/11/19/astrazeneca-submits-nda-for-brilinta-ticagrelor-and-fills-in-details-about-how-it-works/2009-11-19T14:09:46+00:00monthlyhttp://cardiobrief.org/2009/11/18/ahaaccscai-release-updated-stemi-and-pci-guidelines/2009-11-18T21:12:19+00:00monthlyhttp://cardiobrief.org/2009/11/17/fda-issues-public-health-advisory-on-interaction-between-clopidogrel-and-omeprazole/2009-11-17T23:31:53+00:00monthlyhttp://cardiobrief.org/2009/11/16/aha-arbiters-sunday-roller-coaster-ride-in-orlando/2009-11-17T21:45:59+00:00monthlyhttp://cardiobrief.org/2009/11/17/ken-baughman-dies-after-a-traffic-accident-in-orlando-during-aha/2010-02-18T08:18:55+00:00monthlyhttp://cardiobrief.org/2009/11/16/new-warnings-added-to-plavix-clopidogrel-label/2009-11-17T04:23:20+00:00monthlyhttp://cardiobrief.org/2009/11/16/aha-early-repolarization-on-ecg-associated-with-increased-risk-of-cardiac-death/2009-11-16T19:00:20+00:00monthlyhttp://cardiobrief.org/2009/11/15/niacin-to-take-center-stage-as-it-beats-ezetimibe-in-arbiter-6/2009-11-16T12:04:36+00:00monthlyhttp://cardiobrief.org/2009/11/15/aha-biventricular-pacing-preserves-lv-shape-and-function/2009-12-01T05:01:06+00:00monthlyhttp://cardiobrief.org/2009/11/15/aha-cangrelor-fails-to-find-a-championship-season/2009-11-15T16:44:20+00:00monthlyhttp://cardiobrief.org/2009/11/15/aha-ticagrelor-found-beneficial-in-stemi-subset-of-plato/2009-11-15T14:43:57+00:00monthlyhttp://cardiobrief.org/2009/11/14/the-empire-strikes-back-mercks-richard-pasternak-downgrades-arbiter-6/2009-11-14T23:46:23+00:00monthlyhttp://cardiobrief.org/2009/11/13/editorial-why-arbiter-6-is-important-and-not-important/2009-11-14T22:18:57+00:00monthlyhttp://cardiobrief.org/2009/11/13/26000-patients-enrolled-in-timi-50-trial-of-novel-antiplatelet-agent/2009-11-13T17:56:05+00:00monthlyhttp://cardiobrief.org/2009/11/12/william-ganz-co-inventor-of-catheter-and-early-promoter-of-thrombolysis-dead-at-90/2009-11-13T01:18:29+00:00monthlyhttp://cardiobrief.org/2009/11/13/get-ready-for-the-aha-in-orlando/2009-11-13T01:14:55+00:00monthlyhttp://cardiobrief.org/2009/11/11/fda-sends-warning-letter-to-ucla-cardiologist-charles-mckay/2009-11-12T19:56:48+00:00monthlyhttp://cardiobrief.org/2009/11/11/nejm-study-finds-risks-but-no-benefits-for-renal-revascularization/2009-11-11T22:03:45+00:00monthlyhttp://cardiobrief.org/2009/11/10/jama-statins-reduce-gallstones-simplified-lipid-assessment-without-fasting/2009-11-10T21:04:22+00:00monthlyhttp://cardiobrief.org/2009/11/10/arbiter-6-family-feud-and-the-survey-says/2009-11-10T19:22:30+00:00monthlyhttp://cardiobrief.org/2009/11/09/boston-scientific-issues-statement-on-the-death-of-donald-baim/2009-11-09T21:19:19+00:00monthlyhttp://cardiobrief.org/2009/11/09/observational-study-finds-increased-adverse-outcomes-with-increased-usage-of-carotid-stenting/2009-11-09T21:13:38+00:00monthlyhttp://cardiobrief.org/2009/11/06/donald-baim-interventional-cardiologist-and-boston-scientific-executive-dead-at-59/2009-11-07T13:54:55+00:00monthlyhttp://cardiobrief.org/2009/11/08/play-the-cme-game-at-home-or-at-the-aha/2009-11-10T22:08:03+00:00monthlyhttp://cardiobrief.org/2009/11/06/boston-scientific-closes-one-case-for-296-million-and-discloses-a-new-subpoena/2009-11-06T17:36:07+00:00monthlyhttp://cardiobrief.org/2009/11/05/ny-times-why-icds-are-like-maseratis-and-not-hondas/2009-11-06T01:49:13+00:00monthlyhttp://cardiobrief.org/2009/11/05/heartmate-ii-bypasses-fda-panel-and-may-get-destination-therapy-indication-soon/2009-11-05T18:06:37+00:00monthlyhttp://cardiobrief.org/2009/11/04/nejm-on-pump-cabg-beats-off-pump-cabg-at-one-year/2009-11-04T20:25:29+00:00monthlyhttp://cardiobrief.org/2009/11/03/cheerleading-for-science-anybody-have-a-better-idea/2009-11-03T18:31:44+00:00monthlyhttp://cardiobrief.org/2009/11/02/massachusetts-cardiologist-sues-lahey-clinic-after-being-fired-claims-hospital-had-close-ties-to-medtronic/2009-11-03T00:34:46+00:00monthlyhttp://cardiobrief.org/2009/11/02/small-niacin-imaging-study-looms-large-in-the-run-up-to-arbiter-6/2009-11-02T23:40:35+00:00monthlyhttp://cardiobrief.org/2009/11/02/fda-refuses-to-file-merck-application-for-ezetimibeatorvastatin-combination/2009-11-02T21:13:05+00:00monthlyhttp://cardiobrief.org/2009/11/02/exenatide-byetta-gains-first-line-indication-from-fda-but-also-a-warning/2009-11-02T20:43:43+00:00monthlyhttp://cardiobrief.org/2009/11/02/arbiter-6-wall-street-chorus-predicts-outcome-publication-and-editorials/2009-11-02T20:20:45+00:00monthlyhttp://cardiobrief.org/2009/11/02/beta-blockers-for-noncardiac-surgery-deemphasized-in-revised-accaha-guidelines/2009-11-02T15:58:07+00:00monthlyhttp://cardiobrief.org/2009/08/18/wall-street-guesses-arbiter-6-will-be-aha-late-breaker/2009-11-02T14:43:00+00:00monthlyhttp://cardiobrief.org/2009/08/27/arbiter-6-scheduled-as-aha-late-breaker-kastelein-to-be-discussant/2009-11-02T14:42:32+00:00monthlyhttp://cardiobrief.org/2009/07/08/arbiter-6-halts-trial-comparing-ezetimibe-and-niacin-terminated-early-by-steering-committee/2009-11-02T14:40:21+00:00monthlyhttp://cardiobrief.org/2009/10/30/halloween-trick-dont-treat-diabetes-with-esas/2009-10-31T01:55:27+00:00monthlyhttp://cardiobrief.org/2009/10/30/astrazeneca-update-on-ticagrelor-brilinta-raises-questions-about-reduced-efficacy-with-high-dose-aspirin/2009-10-30T17:30:05+00:00monthlyhttp://cardiobrief.org/2009/10/29/halloween-to-arrive-early-this-year-with-presentation-of-treat/2009-10-29T20:50:26+00:00monthlyhttp://cardiobrief.org/2009/10/29/study-suggests-statins-may-prevent-flu-deaths/2009-10-31T14:33:14+00:00monthlyhttp://cardiobrief.org/2009/02/23/chronology-of-prasugrel-controversy/2009-10-29T03:40:20+00:00monthlyhttp://cardiobrief.org/2009/10/28/uks-nice-allows-limited-use-of-prasugrel/2009-10-29T03:36:45+00:00monthlyhttp://cardiobrief.org/2009/10/28/review-article-highlights-differences-between-european-and-north-american-stemi-guidelines/2009-10-28T19:02:02+00:00monthlyhttp://cardiobrief.org/2009/10/27/senator-queries-nih-about-ballantyne-and-other-nih-grantees-who-took-vytorin-money/2009-10-27T19:52:02+00:00monthlyhttp://cardiobrief.org/2009/10/27/medicare-advisory-committee-delivers-mixed-review-for-af-catheter-ablation/2009-10-27T17:54:49+00:00monthlyhttp://cardiobrief.org/2009/10/26/fda-advisory-committee-to-review-primary-prevention-indication-for-crestor-rosuvastatin/2009-10-27T14:37:43+00:00monthlyhttp://cardiobrief.org/2009/10/26/women-and-mi-increasing-incidence-but-improved-survival/2009-10-26T20:48:28+00:00monthlyhttp://cardiobrief.org/2009/10/24/duke-cardiologist-to-be-new-president-of-gladstone-institutes/2009-10-24T22:03:07+00:00monthlyhttp://cardiobrief.org/2009/10/19/telmisartan-gets-fda-approval-for-cv-prevention-in-acei-intolerant-patients/2009-10-23T13:39:21+00:00monthlyhttp://cardiobrief.org/2009/10/22/betsy-nabel-to-leave-nhlbi-to-become-president-of-the-brigham/2009-10-23T00:26:56+00:00monthlyhttp://cardiobrief.org/2009/10/22/lancet-liraglutide-shows-considerable-promise-in-weight-loss-trial/2009-11-06T15:44:48+00:00monthlyhttp://cardiobrief.org/2009/03/13/new-diabetes-drugs-juggled-by-fda/2009-10-22T18:12:09+00:00monthlyhttp://cardiobrief.org/2009/10/21/fda-turns-down-kings-nda-for-corvue-binodenoson/2009-10-21T20:18:18+00:00monthlyhttp://cardiobrief.org/2009/10/20/medco-launches-14000-patient-head-to-head-comparison-of-clopidogrel-and-prasugrel/2009-10-21T09:43:53+00:00monthlyhttp://cardiobrief.org/2009/10/20/hospitals-getting-with-the-guidelines-are-not-getting-with-aldosterone-antagonism/2009-10-20T18:33:09+00:00monthlyhttp://cardiobrief.org/2009/10/16/more-allegations-about-enhance-fiasco-laid-out-in-vytorin-lawsuit-complaint/2009-10-16T18:15:26+00:00monthlyhttp://cardiobrief.org/2009/10/16/study-raises-concerns-about-trauma-treatment-in-growing-population-on-warfarin/2009-10-16T14:29:21+00:00monthlyhttp://cardiobrief.org/2009/10/16/crestor-gains-pediatric-fh-indication-from-fda/2009-10-16T13:18:06+00:00monthlyhttp://cardiobrief.org/2009/10/15/iom-report-smoking-bans-cut-heart-attacks-in-smokers-and-nonsmokers/2009-10-15T16:50:20+00:00monthlyhttp://cardiobrief.org/2009/10/14/meta-analysis-suggests-statins-may-help-fight-infections/2009-10-14T16:16:43+00:00monthlyhttp://cardiobrief.org/2009/10/13/brave-new-world-zen-trial-to-test-des-for-ed/2009-10-13T19:54:23+00:00monthlyhttp://cardiobrief.org/2009/10/13/10-years-after-columbia-heart-surgery-study-still-causing-problems/2009-10-12T23:16:34+00:00monthlyhttp://cardiobrief.org/2009/10/12/study-finds-increased-use-of-glucose-lowering-treatments-at-the-expense-of-statins-and-antihypertensives/2009-10-12T20:12:11+00:00monthlyhttp://cardiobrief.org/2009/10/06/elizabeth-taylor-twitters-the-news-shes-about-to-get-an-evalve-mitraclip-mitral-valve/2009-10-09T04:10:52+00:00monthlyhttp://cardiobrief.org/2009/10/08/lancet-retracts-cooperate-trial-of-dual-ras-inhibition-and-spanks-lead-author-for-serious-misconduct/2009-10-09T00:16:13+00:00monthlyhttp://cardiobrief.org/2009/10/08/erosions-and-late-stage-thrombi-more-prevalent-in-women-and-younger-sudden-death-victims/2009-10-08T18:56:04+00:00monthlyhttp://cardiobrief.org/2009/10/07/october-thought-experiment-suppose-the-world-series-were-covered-like-the-nobel-prizes/2009-10-07T19:52:23+00:00monthlyhttp://cardiobrief.org/2009/10/05/hypertension-in-china/2009-10-07T03:14:57+00:00monthlyhttp://cardiobrief.org/2009/10/06/9-nontraditional-risk-factors-fail-to-gain-uspstf-recommendations-crp-comes-close/2009-10-06T19:28:30+00:00monthlyhttp://cardiobrief.org/2009/10/05/fda-posts-full-drug-approval-package-for-prasugrel/2009-10-05T17:35:27+00:00monthlyhttp://cardiobrief.org/2009/10/05/onglyza-saxagliptin-gains-european-approval/2009-10-05T15:09:49+00:00monthlyhttp://cardiobrief.org/2009/10/02/1st-patient-enrolled-in-dapt-study-testing-duration-of-antiplatelet-therapy-after-des/2009-10-02T16:08:25+00:00monthlyhttp://cardiobrief.org/2009/10/01/fda-alert-heparin-shipped-after-october-8-will-be-10-less-potent/2009-10-01T20:24:48+00:00monthlyhttp://cardiobrief.org/2009/10/01/lancet-review-will-most-babies-born-now-live-to-100/2009-10-01T15:40:33+00:00monthlyhttp://cardiobrief.org/2009/09/30/reverse-at-2-years-crt-may-help-prevent-progression-in-early-hf/2009-09-30T23:50:40+00:00monthlyhttp://cardiobrief.org/2009/09/29/fish-and-heart-failure-the-one-that-got-away/2009-09-30T00:32:53+00:00monthlyhttp://cardiobrief.org/2009/09/29/invitation-to-readers-my-mighty-team/2009-09-29T23:55:19+00:00monthlyhttp://cardiobrief.org/2009/09/28/home-care-for-acute-decompensated-heart-failure/2009-09-28T14:35:48+00:00monthlyhttp://cardiobrief.org/2009/09/25/fda-adds-pancreatitis-warning-to-januvia-label/2009-09-25T18:22:23+00:00monthlyhttp://cardiobrief.org/2009/09/25/cholesterol-prescriptions-from-senators-schumer-grassley-and-nelson/2010-03-31T18:39:35+00:00monthlyhttp://cardiobrief.org/2009/09/24/tct-cogent-provides-reassurance-on-use-of-ppis-with-clopidogrel/2009-09-25T18:20:55+00:00monthlyhttp://cardiobrief.org/2009/09/24/tct-fame-extends-its-15-minutes-out-to-2-years/2009-09-25T17:33:12+00:00monthlyhttp://cardiobrief.org/2009/09/24/3280/2009-09-24T21:51:18+00:00monthlyhttp://cardiobrief.org/2009/09/23/gregg-stone-no-longer-chairman-of-cardiovascular-research-foundation/2009-09-24T00:29:16+00:00monthlyhttp://cardiobrief.org/2009/09/23/tct-xience-outperforms-taxus-in-spirit-iv-but-no-difference-in-diabetics/2009-09-24T00:29:03+00:00monthlyhttp://cardiobrief.org/2009/09/21/flu-vaccine-may-prevent-flu-triggered-mis/2009-09-23T16:23:33+00:00monthlyhttp://cardiobrief.org/2009/09/22/accaha-publish-new-performance-measures-to-prevent-cv-disease/2009-09-23T16:23:17+00:00monthlyhttp://cardiobrief.org/2009/09/22/senators-ask-columbia-did-martin-leon-fail-to-disclose-millions-of-dollars-received-from-industry/2009-09-23T16:23:06+00:00monthlyhttp://cardiobrief.org/2009/09/21/wall-street-analyst-calls-prasugrel-launch-muted/2009-09-21T20:10:52+00:00monthlyhttp://cardiobrief.org/2009/09/21/circ-smoking-ban/2009-09-21T20:03:29+00:00monthlyhttp://cardiobrief.org/2009/09/18/company-and-wall-street-disagree-over-trial-results-of-diet-drug-lorcaserin/2009-09-18T21:34:47+00:00monthlyhttp://cardiobrief.org/2009/09/18/uk-study-high-risk-associated-with-10-15-year-cut-in-life-expectancy/2009-09-17T15:54:45+00:00monthlyhttp://cardiobrief.org/2009/09/16/nejm-writers-make-case-for-soda-tax/2009-09-17T14:14:10+00:00monthlyhttp://cardiobrief.org/2009/09/16/senate-investigation-uncovers-huge-expenditures-for-vytorin-cme/2009-09-22T21:13:48+00:00monthlyhttp://cardiobrief.org/2009/09/14/study-sheds-light-on-stroke-following-cardiac-surgery/2009-09-16T18:41:39+00:00monthlyhttp://cardiobrief.org/2009/09/14/everybody-in-the-risk-pool-survey-finds-frightening-increase-in-cv-risk/2009-09-14T20:21:14+00:00monthlyhttp://cardiobrief.org/2009/09/14/icds-in-women-a-new-meta-analysis-sparks-criticism/2009-09-14T20:17:57+00:00monthlyhttp://cardiobrief.org/2009/09/13/endothelin-receptor-blocker-darusentan-effective-in-resistant-hypertension/2009-09-12T23:09:01+00:00monthlyhttp://cardiobrief.org/2009/09/11/editor-insists-prasugrel-ghostwriter-go-public/2009-09-12T14:46:48+00:00monthlyhttp://cardiobrief.org/2009/09/10/abbott-to-acquire-evalve-developer-of-minimally-invasive-mitral-valve-repair-devices/2009-09-11T14:55:42+00:00monthlyhttp://cardiobrief.org/2009/09/10/acc-survey-finds-critical-shortage-of-cardiologists-now-and-in-the-future/2009-09-11T14:55:32+00:00monthlyhttp://cardiobrief.org/2009/09/09/phentermine-and-topiramate-a-slimming-combination/2009-09-11T14:55:20+00:00monthlyhttp://cardiobrief.org/2009/09/08/lifetime-exposure-to-lead-linked-to-increased-cv-risk/2009-09-08T18:12:33+00:00monthlyhttp://cardiobrief.org/2009/09/08/dronedarone-less-effective-but-safer-than-amiodarone-study-suggests/2009-09-08T14:50:00+00:00monthlyhttp://cardiobrief.org/2009/09/04/esc-the-shady-side-of-af-treatments/2009-09-08T03:02:49+00:00monthlyhttp://cardiobrief.org/2009/09/06/dr-nobody-in-jama-editors-flap-speaks-his-mind/2009-09-08T03:02:37+00:00monthlyhttp://cardiobrief.org/2009/09/05/circulation-publishes-lengthy-correction-of-mist-paper/2009-09-08T03:02:27+00:00monthlyhttp://cardiobrief.org/2009/09/03/are-low-carb-high-fat-diets-fads/2010-02-05T08:17:21+00:00monthlyhttp://cardiobrief.org/2009/07/07/chronology-of-the-jama-editors-controversy/2009-09-06T15:33:35+00:00monthlyhttp://cardiobrief.org/2009/02/16/pfo-and-migraine-the-next-chapter/2009-09-05T15:18:16+00:00monthlyhttp://cardiobrief.org/2009/09/03/fame-at-esc-benefits-of-ffr-hold-up-at-18-months/2009-09-03T15:46:26+00:00monthlyhttp://cardiobrief.org/2009/09/01/hiding-in-plain-sight-clinical-trial-registration-isnt-working-as-intended/2009-09-11T19:03:01+00:00monthlyhttp://cardiobrief.org/2009/09/02/fda-reviewer-reviews-his-own-prasugrel-review-in-nejm/2009-09-03T02:54:41+00:00monthlyhttp://cardiobrief.org/2009/09/02/syntax-at-esc-at-2-years-mis-in-pci-patients-begin-to-accumulate/2009-09-02T18:16:55+00:00monthlyhttp://cardiobrief.org/2009/09/02/jama-all-aboard-for-pci-but-no-need-to-rush/2009-09-01T21:34:48+00:00monthlyhttp://cardiobrief.org/2009/09/01/kyoto-heart-at-esc-have-arbs-finally-come-of-age/2009-09-01T19:13:22+00:00monthlyhttp://cardiobrief.org/2009/09/01/esc-icdmadit-crt/2009-09-01T08:24:49+00:00monthlyhttp://cardiobrief.org/2009/08/31/jupiter-at-esc-large-absolute-benefit-with-rosuvastatin-in-elderly-patients/2009-09-01T01:04:55+00:00monthlyhttp://cardiobrief.org/2009/08/31/esc-grace-documents-growing-use-of-pci-for-left-main-disease-in-acs/2009-08-31T22:51:51+00:00monthlyhttp://cardiobrief.org/2009/08/31/esc-reassurance-on-concomitant-use-of-ppis-and-antiplatelets/2009-08-31T15:05:21+00:00monthlyhttp://cardiobrief.org/2009/08/30/re-ly-at-esc-dabigatran-in-warfarin-finally-on-the-way-out/2010-02-12T21:10:47+00:00monthlyhttp://cardiobrief.org/2009/08/30/esc-high-dose-clopidogrel-aids-pci-for-acs-current-oasis-7/2009-08-30T23:55:44+00:00monthlyhttp://cardiobrief.org/2009/08/30/esc-ticagrelor-shows-potent-antiplatelet-effect-in-plato/2009-08-30T16:18:21+00:00monthlyhttp://cardiobrief.org/2009/08/30/esc-bivalirudin-and-otamixaban-in-acs/2009-08-30T16:15:44+00:00monthlyhttp://cardiobrief.org/2009/08/30/aaa-at-esc-aspirin-not-beneficial-in-asymptomatic-patients-with-low-abi/2009-08-30T15:07:26+00:00monthlyhttp://cardiobrief.org/2009/08/30/1st-day-esc-hot-lines-68415-randomized-patients/2009-08-30T08:35:40+00:00monthlyhttp://cardiobrief.org/2009/05/11/tacagrelor-bests-clopidogrel-in-l8000-patient-acs-trial-astrazeneca-claims/2009-08-30T06:16:52+00:00monthlyhttp://cardiobrief.org/2009/08/28/routine-use-of-stenting-in-carotid-stenosis-can-no-longer-be-justified/2010-02-27T00:52:26+00:00monthlyhttp://cardiobrief.org/2009/08/26/topol-and-teirstein-argue-about-stents-on-nprs-all-things-considered/2009-08-28T15:40:48+00:00monthlyhttp://cardiobrief.org/2009/08/25/editorial-prescription-for-medical-education-sunshine/2009-08-26T03:13:54+00:00monthlyhttp://cardiobrief.org/2009/08/26/sensitive-troponin-assays-enter-the-fray/2009-08-26T03:03:14+00:00monthlyhttp://cardiobrief.org/2009/08/25/jama-researchers-identify-genetic-variation-that-hinders-clopidogrel-effectiveness/2009-08-25T00:09:35+00:00monthlyhttp://cardiobrief.org/2009/08/24/testosterone-may-be-beneficial-in-hf/2009-08-24T22:51:15+00:00monthlyhttp://cardiobrief.org/2009/08/25/jama-risk-of-death-after-acs-diff-in-men-women/2009-08-21T16:34:56+00:00monthlyhttp://cardiobrief.org/2009/08/20/cardiologist-in-mcallen-texas-sentenced-to-4-years-in-prison/2009-08-21T14:58:56+00:00monthlyhttp://cardiobrief.org/2009/08/20/shanghai-cardiology-conference-putting-the-con-back-in-the-word-conference/2009-08-20T14:51:41+00:00monthlyhttp://cardiobrief.org/2009/08/19/is-it-time-to-change-the-guidelines-for-unprotected-left-main-disease/2009-08-20T01:05:51+00:00monthlyhttp://cardiobrief.org/2009/08/18/bmj-study-questions-whether-ongoing-use-of-rosiglitazone-is-justified-in-any-circumstance/2009-08-19T03:39:40+00:00monthlyhttp://cardiobrief.org/2009/08/18/get-ready-for-the-esc-in-barcelona/2009-08-18T20:18:51+00:00monthlyhttp://cardiobrief.org/2009/08/18/jama-papers-mi-outcomes-improving-hf-not-so-much/2009-08-18T17:35:40+00:00monthlyhttp://cardiobrief.org/2009/08/15/charm-substudy-in-lancet-spotlights-albuminuria-in-hf/2009-08-15T13:21:59+00:00monthlyhttp://cardiobrief.org/2009/08/14/2681/2009-08-14T17:58:29+00:00monthlyhttp://cardiobrief.org/2009/08/14/saxagliptin-now-available-in-the-us/2009-08-14T14:23:52+00:00monthlyhttp://cardiobrief.org/2009/08/05/prasugrel-finally-hits-the-street/2009-08-14T14:21:15+00:00monthlyhttp://cardiobrief.org/2009/08/13/cardio-sis-in-the-lancet-is-130-the-new-140/2009-08-13T23:34:25+00:00monthlyhttp://cardiobrief.org/2009/08/11/fda-official-on-prasugrel-approval-this-has-not-been-a-well-managed-review-process/2009-08-13T18:37:06+00:00monthlyhttp://cardiobrief.org/2009/08/12/nejm-califf-et-al-seek-to-shed-light-on-the-ezetimibe-cancer-controversy/2009-08-13T18:35:14+00:00monthlyhttp://cardiobrief.org/2009/08/11/large-study-increases-concerns-over-tzd-fracture-risk/2009-08-11T19:00:55+00:00monthlyhttp://cardiobrief.org/2009/08/04/pitavastatin-prescribing-information-released-by-fda/2009-08-10T20:58:16+00:00monthlyhttp://cardiobrief.org/2009/08/10/antioxidant-supplements-round-3-harrington-remains-naturally-skeptical/2009-08-10T23:19:01+00:00monthlyhttp://cardiobrief.org/2009/08/09/antioxidants-for-radiation-protection-ehrlich-versus-harrington/2009-09-11T03:00:07+00:00monthlyhttp://cardiobrief.org/2009/08/07/questions-raised-about-ucla-cardiologists-endorsement-of-nutritional-supplement/2009-08-09T17:33:11+00:00monthlyhttp://cardiobrief.org/2009/08/05/apixaban-advances-or-does-it/2009-08-06T02:55:44+00:00monthlyhttp://cardiobrief.org/2009/08/03/pitavastatin-gains-fda-approval/2009-08-06T02:53:41+00:00monthlyhttp://cardiobrief.org/2009/08/03/new-review-bolsters-evidence-for-benefits-of-fish-oil/2009-08-06T02:52:53+00:00monthlyhttp://cardiobrief.org/2009/07/31/fda-approves-saxagliptin-onglyza/2009-08-06T02:52:06+00:00monthlyhttp://cardiobrief.org/2009/07/31/extreme-cardiology-culture-califf-harrington-topol-teirstein/2009-07-31T19:30:59+00:00monthlyhttp://cardiobrief.org/2009/07/29/senate-hearings-lay-groundwork-for-assault-on-cme/2009-07-30T13:48:39+00:00monthlyhttp://cardiobrief.org/2009/07/29/fda-advisory-panel-gives-mixed-response-to-telmisartan/2009-07-30T03:58:06+00:00monthlyhttp://cardiobrief.org/2009/07/28/fda-cardiorenal-panel-votes-against-binodenoson/2009-07-29T03:38:37+00:00monthlyhttp://cardiobrief.org/2009/07/28/senate-committee-to-hold-hearings-on-cme/2009-07-28T19:30:55+00:00monthlyhttp://cardiobrief.org/2009/07/28/des-usage-plunged-immediately-following-warnings-at-esc-2006/2009-07-28T18:31:34+00:00monthlyhttp://cardiobrief.org/2009/07/28/dronedarone-multaq-to-cost-9day/2010-06-10T10:59:01+00:00monthlyhttp://cardiobrief.org/2009/07/27/fda-review-raises-questions-about-expanded-indication-for-telmisartan/2009-07-27T19:13:01+00:00monthlyhttp://cardiobrief.org/2009/07/24/fda-briefing-documents-binodenoson-in-for-some-tough-questions/2009-07-24T17:18:20+00:00monthlyhttp://cardiobrief.org/2009/07/22/fda-panel-recommends-approval-of-medtronics-melody-transcatheter-pulmonary-valve/2009-09-15T22:13:18+00:00monthlyhttp://cardiobrief.org/2009/07/23/best-selling-cardiovascular-drugs-of-t2008/2009-07-24T03:39:54+00:00monthlyhttp://cardiobrief.org/2009/07/22/cardiology-strikes-back-bove-lewin-weber-black-defend-ties-to-industry/2009-07-22T20:37:38+00:00monthlyhttp://cardiobrief.org/2009/07/21/shocking-studies-in-jama-show-benefits-of-healthy-lifestyles/2009-07-21T17:58:51+00:00monthlyhttp://cardiobrief.org/2009/07/21/2434/2009-07-21T17:57:49+00:00monthlyhttp://cardiobrief.org/2009/07/20/salt-studies/2009-07-21T12:45:19+00:00monthlyhttp://cardiobrief.org/2009/07/17/courage-results-get-support-from-angiography-study-and-califf-editorial/2009-07-18T02:09:03+00:00monthlyhttp://cardiobrief.org/2009/07/16/cleveland-clinic-again-leads-us-news-world-report-list-for-heart-hospitals/2009-07-17T02:18:55+00:00monthlyhttp://cardiobrief.org/2009/07/16/prasugrel-priced-18-more-than-clopidogrel-in-us-by-lillydaiichi-sankyo/2009-07-16T15:03:37+00:00monthlyhttp://cardiobrief.org/2009/07/15/nejm-bhatt-editorial-evaluates-prasugrel-in-clinical-practice/2009-07-15T20:58:33+00:00monthlyhttp://cardiobrief.org/2009/07/15/nejm-open-vein-graft-harvesting-preferable-to-endoscopic-harvesting/2009-07-15T19:50:58+00:00monthlyhttp://cardiobrief.org/2009/07/14/prasugrel-approval-aftermath-now-the-real-battle-begins/2009-07-14T22:31:49+00:00monthlyhttp://cardiobrief.org/2009/07/13/study-estimates-cancer-risks-for-widespread-calcium-screening/2009-07-14T18:20:24+00:00monthlyhttp://cardiobrief.org/2009/07/13/teenage-girl-thriving-after-late-donor-cardiectomy-10-years-after-heterotopic-transplant/2009-07-13T19:37:34+00:00monthlyhttp://cardiobrief.org/2009/07/12/barcelona-list-of-esc-hot-lines-clinical-trial-updates-and-science-hot-lines/2009-07-13T16:38:11+00:00monthlyhttp://cardiobrief.org/2009/07/10/fda-approves-prasugrel/2009-07-10T21:08:09+00:00monthlyhttp://cardiobrief.org/2009/07/11/lock-and-load-acc-takes-aim-at-proposed-cms-cuts-to-cardiologists/2009-07-12T08:42:50+00:00monthlyhttp://cardiobrief.org/2009/07/10/congressman-fda-admits-kaul-should-not-have-been-dismissed-from-prasugrel-panel/2009-07-11T23:48:27+00:00monthlyhttp://cardiobrief.org/2009/07/10/down-the-memory-hole-jama-editors-rewrite-history-and-remove-original-editorial/2009-07-10T04:26:39+00:00monthlyhttp://cardiobrief.org/2009/07/07/who-brought-the-dogs-in-jama-editors-morph-from-pitbulls-to-lapdogs/2009-07-10T03:03:22+00:00monthlyhttp://cardiobrief.org/2009/07/09/cms-hospital-compare-website-adds-mi-and-hf-readmission-data/2009-07-10T01:08:04+00:00monthlyhttp://cardiobrief.org/2009/07/08/ahrq-gives-mixed-reviews-for-rf-catheter-ablation-of-af/2009-07-08T16:28:38+00:00monthlyhttp://cardiobrief.org/2009/07/07/jama-letter-writers-debate-value-of-accaha-guidelines/2009-07-07T20:46:55+00:00monthlyhttp://cardiobrief.org/2009/07/05/lancet-famotidine-cuts-upper-gi-risk-in-patients-taking-low-dose-aspirin/2009-07-05T22:11:13+00:00monthlyhttp://cardiobrief.org/2009/07/05/hypertension-pioneer-and-rebel-proposes-a-different-treatment-approach/2009-07-02T16:45:25+00:00monthlyhttp://cardiobrief.org/2009/07/04/cost-effectiveness-research-priorities-in-cardiovascular-medicine-from-the-iom-recommendations/2009-07-02T15:44:40+00:00monthlyhttp://cardiobrief.org/2009/07/02/dronedarone-approved-by-fda-for-atrial-fibrillation-or-atrial-flutter/2009-07-02T14:43:24+00:00monthlyhttp://cardiobrief.org/2009/07/01/fda-adds-boxed-warnings-to-varenicline-and-buproprion/2009-07-01T20:33:02+00:00monthlyhttp://cardiobrief.org/2009/07/01/armyda-recapture-shows-benefits-of-statin-reload-before-pci/2009-07-26T22:57:44+00:00monthlyhttp://cardiobrief.org/2009/06/30/jama-studies-raise-questions-about-crp-and-other-biomarkers/2009-07-01T17:00:57+00:00monthlyhttp://cardiobrief.org/2009/06/29/jacc-white-paper-urges-cautious-approach-to-triple-antithrombotic-therapy/2009-06-29T17:12:44+00:00monthlyhttp://cardiobrief.org/2009/06/27/michael-jacksons-doctor-cardiologist-or-not/2009-06-27T23:58:17+00:00monthlyhttp://cardiobrief.org/2009/06/27/takedas-alogliptin-delayed-for-at-least-2-years/2009-06-27T19:50:40+00:00monthlyhttp://cardiobrief.org/2009/06/26/easd-raises-concerns-about-possible-link-between-lantus-insulin-and-cancer/2009-06-26T22:50:39+00:00monthlyhttp://cardiobrief.org/2009/06/25/doug-zipes-on-michael-jacksons-death/2009-06-26T22:47:16+00:00monthlyhttp://cardiobrief.org/2009/06/25/transfer-ami-definitive-endorsement-of-early-pci-after-fibrinolysis/2009-06-25T13:46:29+00:00monthlyhttp://cardiobrief.org/2009/06/24/framingham-first-degree-av-block-not-benign/2009-06-24T19:16:10+00:00monthlyhttp://cardiobrief.org/2009/06/24/new-percutaneous-mitral-repair-device-appears-promising-in-small-study/2009-06-24T14:14:51+00:00monthlyhttp://cardiobrief.org/2009/06/22/braunwald-japanese-cta-study-may-be-future-landmark/2009-06-23T18:55:36+00:00monthlyhttp://cardiobrief.org/2009/06/23/shape-bill-passes-in-texas-requiring-reimbursement-for-mi-screening/2009-06-23T18:36:45+00:00monthlyhttp://cardiobrief.org/2009/06/23/boston-scientific-says-madit-crt-meets-primary-endpoint-crt-slows-hf-progression/2009-06-23T14:48:51+00:00monthlyhttp://cardiobrief.org/2009/06/05/1828/2009-06-22T19:24:56+00:00monthlyhttp://cardiobrief.org/2009/03/03/ppis/2010-03-17T06:46:21+00:00monthlyhttp://cardiobrief.org/2009/06/12/lilly-responds-to-serebruany-attack-on-triton-timi-38/2009-06-22T19:24:27+00:00monthlyhttp://cardiobrief.org/2009/05/06/scai-clopidogrelppi-wed-1130am/2009-06-22T19:23:01+00:00monthlyhttp://cardiobrief.org/2009/06/08/bring-it-on-the-battle-over-bari-2d/2009-06-22T18:49:26+00:00monthlyhttp://cardiobrief.org/2009/06/12/what-do-fda-insiders-really-think-of-prasugrel/2009-06-22T18:34:58+00:00monthlyhttp://cardiobrief.org/2009/06/19/no-recession-in-cardiology-starting-salaries-for-new-cardiologists-remain-strong/2009-12-04T22:27:25+00:00monthlyhttp://cardiobrief.org/2009/06/19/fda-official-defends-integrity-of-prasugrel-review/2009-06-19T15:44:16+00:00monthlyhttp://cardiobrief.org/2009/06/21/europace-update-af-in-athletes-drivers-with-icds-more/2009-06-19T14:21:51+00:00monthlyhttp://cardiobrief.org/2009/06/18/court-transcripts-show-cardiologists-debating-vioxx-in-australian-court/2009-06-19T02:28:02+00:00monthlyhttp://cardiobrief.org/2009/06/18/bp-complex-interplay-between-genes-and-environment/2009-06-17T15:08:48+00:00monthlyhttp://cardiobrief.org/2009/06/17/lowering-bp-small-steps-big-results/2009-06-17T14:05:34+00:00monthlyhttp://cardiobrief.org/2009/06/16/rivaroxaban-in-acs-more-bleeding-no-benefit-over-dual-therapy/2009-06-17T03:31:34+00:00monthlyhttp://cardiobrief.org/2009/06/16/triple-antiplatelet-therapy-for-primary-pci/2009-06-16T15:31:01+00:00monthlyhttp://cardiobrief.org/2009/06/15/pioglitazone-to-reduce-restenosis-the-next-frontier/2009-06-15T23:24:18+00:00monthlyhttp://cardiobrief.org/2009/06/15/dr-barack-obama-speaks-out-on-cardiology/2009-06-15T21:22:49+00:00monthlyhttp://cardiobrief.org/2009/06/16/study-links-psoriasis-and-atherosclerosis/2009-06-15T19:32:03+00:00monthlyhttp://cardiobrief.org/2009/06/11/enrollment-resumed-in-controversial-nih-chelation-trial/2009-09-28T17:06:20+00:00monthlyhttp://cardiobrief.org/2009/06/10/lipoproteina-associated-with-mi/2009-06-23T03:36:39+00:00monthlyhttp://cardiobrief.org/2009/06/11/bmc-therapy-still-alive-after-5-years/2009-06-10T13:45:31+00:00monthlyhttp://cardiobrief.org/2009/06/10/study-in-jama-explores-cutting-radiation-exposure-in-ct-angiography/2009-06-10T13:44:21+00:00monthlyhttp://cardiobrief.org/2009/06/09/study-shows-it-may-be-possible-to-diagnose-diabetes-sooner/2009-06-09T19:02:20+00:00monthlyhttp://cardiobrief.org/2009/06/09/research-suggests-sleep-blood-pressure-link/2009-06-09T17:47:06+00:00monthlyhttp://cardiobrief.org/2009/06/07/bari-2d-will-it-fortify-courage/2009-06-25T19:47:00+00:00monthlyhttp://cardiobrief.org/2009/06/09/uks-nice-favors-restricted-approval-for-prasugrel/2009-06-09T16:34:49+00:00monthlyhttp://cardiobrief.org/2009/06/08/lancetada-promising-phase-2-studies-for-liraglutide-and-aleglitazar/2009-08-12T00:54:30+00:00monthlyhttp://cardiobrief.org/2009/06/05/cardiologists-in-the-news-1-sentenced-to-jail-1-buys-icds-from-girlfriend/2009-06-05T15:11:51+00:00monthlyhttp://cardiobrief.org/2009/06/05/record-and-bari-2d-to-be-presented-this-weekend-at-ada/2009-06-05T14:18:28+00:00monthlyhttp://cardiobrief.org/2009/06/04/high-healthcare-costs-more-bankruptcies-and-unfilled-prescriptions/2009-06-04T16:19:34+00:00monthlyhttp://cardiobrief.org/2009/06/03/dallas-heart-study-calcium-screening-adds-little-to-traditional-risk-factors/2009-06-04T00:20:15+00:00monthlyhttp://cardiobrief.org/2009/06/03/serebruany-and-wolfe-ask-fda-to-halt-review-of-prasugrel/2009-06-03T20:31:55+00:00monthlyhttp://cardiobrief.org/2009/06/02/hecht-editorial-ct-angiography-is-ready-for-prime-time/2009-06-02T17:28:31+00:00monthlyhttp://cardiobrief.org/2009/06/02/taubman-new-ceo-in-rochester-after-spinal-injury-to-predecessor-berk/2009-06-02T15:32:37+00:00monthlyhttp://cardiobrief.org/2009/06/02/fda-rejects-bucindolol-and-questions-trial-integrity/2009-06-02T15:01:11+00:00monthlyhttp://cardiobrief.org/2009/06/01/krumholz-systematic-and-continuous-measuring-of-performance-is-not-part-of-the-culture-of-medicine/2009-06-01T15:35:46+00:00monthlyhttp://cardiobrief.org/2009/05/31/new-yorker-%e2%80%9cwe-took-a-wrong-turn-when-doctors-stopped-being-doctors-and-became-businessmen-%e2%80%9d/2009-06-01T03:08:31+00:00monthlyhttp://cardiobrief.org/2009/05/29/study-finds-no-benefit-in-routine-ecg-screening-for-young-athletes/2009-05-29T15:42:27+00:00monthlyhttp://cardiobrief.org/2009/05/28/antithrombotic-trialists-collaboration-questions-value-of-aspirin-in-primary-prevention/2009-06-23T09:05:22+00:00monthlyhttp://cardiobrief.org/2009/03/03/comment-if-prasugrel-is-delayed-who-is-to-blame/2009-05-28T14:21:37+00:00monthlyhttp://cardiobrief.org/2009/05/27/explosive-increase-in-type-1-diabetes-predicted/2009-05-27T15:09:47+00:00monthlyhttp://cardiobrief.org/2009/05/26/arterial-damage-found-in-teens-and-young-adults-with-obesity-or-type-2-diabetes/2009-05-26T17:44:44+00:00monthlyhttp://cardiobrief.org/2009/05/26/is-bigger-really-better-study-compares-nfl-players-to-the-rest-of-us/2009-05-24T22:01:45+00:00monthlyhttp://cardiobrief.org/2009/05/25/study-raises-concerns-about-coronary-aneurysms-after-des-implantation/2009-05-24T19:22:18+00:00monthlyhttp://cardiobrief.org/2009/05/23/robert-furchgott-nobel-winner-for-no-dead-at-92/2009-05-23T14:55:22+00:00monthlyhttp://cardiobrief.org/2009/05/22/the-super-bowl-really-does-mean-life-or-death/2009-05-22T16:46:34+00:00monthlyhttp://cardiobrief.org/2009/05/21/field-fenofibrates-cuts-amputation-in-type-2-diabetics/2009-05-21T16:52:32+00:00monthlyhttp://cardiobrief.org/2009/05/21/zipes-testifies-in-australian-vioxx-trial/2009-05-21T15:44:14+00:00monthlyhttp://cardiobrief.org/2009/05/21/lancet-meta-analysis-revives-hope-for-coronary-benefits-of-intensive-glucose-control-in-type-2-diabetics/2009-05-21T15:10:38+00:00monthlyhttp://cardiobrief.org/2009/05/20/timacs-nejm-wed-5-pm/2009-05-20T23:41:31+00:00monthlyhttp://cardiobrief.org/2009/05/20/renaissance-man-eric-topol-rock-star-model-wireless-expert-skit-subject/2009-05-20T17:46:41+00:00monthlyhttp://cardiobrief.org/2009/05/19/jama-this-week-bone-marrow-cell-therapy-cardiorespiratory-fitness/2009-05-19T18:39:19+00:00monthlyhttp://cardiobrief.org/2009/05/19/ohio-cardiologist-sues-heart-center-alleging-abuse-of-patients-and-medicare-fraud/2009-05-19T14:55:27+00:00monthlyhttp://cardiobrief.org/2009/05/18/obesity-paradox-more-cv-disease-but-better-outcome/2009-05-18T15:37:20+00:00monthlyhttp://cardiobrief.org/2009/05/18/jacc-publishes-revised-appropriate-use-criteria-for-radionuclide-imaging/2009-05-18T15:03:46+00:00monthlyhttp://cardiobrief.org/2009/05/15/icds-in-the-real-world-good-survival-but-many-shocks/2009-05-15T14:16:55+00:00monthlyhttp://cardiobrief.org/2009/05/14/madit-ii-at-8-years-1-life-saved-for-every-six-patients/2009-05-30T03:46:52+00:00monthlyhttp://cardiobrief.org/2009/05/14/psychotropic-drugs-increase-risk-of-sudden-death-in-acs/2009-05-14T14:49:38+00:00monthlyhttp://cardiobrief.org/2009/05/13/both-high-and-low-estradiol-levels-linked-to-higher-mortality-in-men-with-hf/2009-05-13T17:06:19+00:00monthlyhttp://cardiobrief.org/2009/05/13/the-medicines-company-discontinues-phase-3-champion-clinical-trial-program-of-cangrelor/2009-05-13T14:16:46+00:00monthlyhttp://cardiobrief.org/2009/05/12/your-mother-was-wrong-dont-take-vitamins-before-exercise/2009-05-12T23:58:49+00:00monthlyhttp://cardiobrief.org/2009/05/12/acc-takes-firm-stand-against-lanyards-and-tote-bags/2009-05-12T15:23:41+00:00monthlyhttp://cardiobrief.org/2009/05/11/archives-new-reports-from-allhat-wise-and-dash/2009-05-11T18:05:39+00:00monthlyhttp://cardiobrief.org/2009/05/11/aha-position-on-comparative-effectiveness-differs-from-acc-position/2009-05-11T17:44:34+00:00monthlyhttp://cardiobrief.org/2009/05/10/bp-genes-small-variations-lead-to-large-increases-in-risk/2009-05-11T15:24:32+00:00monthlyhttp://cardiobrief.org/2009/05/06/2-studied-in-nejm-offer-comforting-support-for-des/2009-05-11T03:43:36+00:00monthlyhttp://cardiobrief.org/2009/05/07/new-mitral-annuloplasty-device-shows-promise-in-early-trial/2009-05-11T03:42:47+00:00monthlyhttp://cardiobrief.org/2009/05/08/1529/2009-05-11T03:41:37+00:00monthlyhttp://cardiobrief.org/2009/05/08/new-pfo-closure-device-may-be-safe-and-effective/2009-05-11T03:40:53+00:00monthlyhttp://cardiobrief.org/2009/05/05/prasugrel-not-affected-by-common-cyp-genetic-variations/2009-06-25T19:49:42+00:00monthlyhttp://cardiobrief.org/2009/05/05/1473/2009-05-05T13:59:06+00:00monthlyhttp://cardiobrief.org/2009/05/04/record-4-rivaroxaban-beats-enoxaparin-after-knee-replacement/2009-05-04T16:46:05+00:00monthlyhttp://cardiobrief.org/2009/05/01/confessions-of-a-repentant-cardiologist/2009-05-01T21:13:34+00:00monthlyhttp://cardiobrief.org/2009/04/29/dronedarone-debut-will-it-be-successful/2009-09-11T19:13:24+00:00monthlyhttp://cardiobrief.org/2009/04/30/on-the-radar-bari-2d-could-be-the-next-courage/2009-04-30T14:54:05+00:00monthlyhttp://cardiobrief.org/2009/04/30/meta-analysis-increased-mortality-in-cancer-patients-treated-with-epoetin-and-darbepoetin/2009-04-30T03:04:21+00:00monthlyhttp://cardiobrief.org/2009/04/29/new-imaging-technique-may-help-monitor-vulnerable-plaque/2009-04-29T23:56:12+00:00monthlyhttp://cardiobrief.org/2009/04/28/pfizer-reports-drop-in-lipitor-sales/2009-04-28T15:20:54+00:00monthlyhttp://cardiobrief.org/2009/04/28/conflicts-of-interest-threaten-publics-trust-in-medicine-iom-report/2009-04-28T14:07:13+00:00monthlyhttp://cardiobrief.org/2009/04/28/dual-antiplatelet-therapy-linked-to-more-post-cabg-infections/2009-04-27T18:04:58+00:00monthlyhttp://cardiobrief.org/2009/04/26/statins-linked-to-reduced-incidence-of-prostate-cancer/2009-04-27T14:36:26+00:00monthlyhttp://cardiobrief.org/2009/04/26/football-moms-go-red/2009-04-26T22:54:17+00:00monthlyhttp://cardiobrief.org/2009/04/27/good-kitty-romicat-ct-to-rule-out-mi/2009-04-24T15:35:36+00:00monthlyhttp://cardiobrief.org/2009/04/24/is-the-party-over-phrma-publishes-new-guidelines-on-clinical-trials/2009-04-24T14:40:43+00:00monthlyhttp://cardiobrief.org/2009/04/23/fda-panel-gives-cautious-nod-to-the-watchman/2009-04-24T13:30:06+00:00monthlyhttp://cardiobrief.org/2009/04/23/two-radically-different-approaches-to-financial-incentives/2009-04-24T00:12:13+00:00monthlyhttp://cardiobrief.org/2009/04/23/fda-extends-review-of-saxagliptin-until-july-30/2009-04-23T13:57:11+00:00monthlyhttp://cardiobrief.org/2009/04/22/fda-is-it-time-for-the-watchman/2009-04-22T23:11:45+00:00monthlyhttp://cardiobrief.org/2009/04/22/acc-defends-partnership-with-industry-group-to-separate-clinical-and-cost-effectiveness-studies/2009-04-22T19:44:57+00:00monthlyhttp://cardiobrief.org/2009/04/21/electricians-do-it-better/2009-04-21T20:27:00+00:00monthlyhttp://cardiobrief.org/2009/04/21/bring-it-on-stanford-cardiology-fellows-challenge-49ers-to-push-up-contest/2009-04-21T14:09:59+00:00monthlyhttp://cardiobrief.org/2009/04/20/stemi-networks-key-to-rapid-reperfusion/2009-04-20T14:36:29+00:00monthlyhttp://cardiobrief.org/2009/04/20/jacc-white-paper-clarifies-role-of-cardiovascular-mr-in-myocarditis/2009-04-20T14:19:09+00:00monthlyhttp://cardiobrief.org/2009/04/17/jama-imbroglio-the-shrink-strikes-back/2009-04-17T15:09:18+00:00monthlyhttp://cardiobrief.org/2009/04/16/courage-oat-persistent-doubts-among-interventionalists/2009-04-16T16:23:54+00:00monthlyhttp://cardiobrief.org/2009/04/15/mr-angiography-continues-to-advance-but-still-limited/2009-04-15T16:35:17+00:00monthlyhttp://cardiobrief.org/2009/04/15/gissi-af-valsartan-fails-to-prevent-af-recurrence/2009-04-15T16:34:42+00:00monthlyhttp://cardiobrief.org/2009/01/02/palmaz-wsj-article/2009-04-15T16:16:18+00:00monthlyhttp://cardiobrief.org/2009/04/14/cardiology-residents-a-tale-of-two-houses-and-3-cities/2009-04-15T16:14:24+00:00monthlyhttp://cardiobrief.org/2009/04/14/francis-collins-reported-to-be-next-nih-director/2009-04-14T17:40:47+00:00monthlyhttp://cardiobrief.org/2009/04/14/1279/2009-04-17T02:56:41+00:00monthlyhttp://cardiobrief.org/2009/04/13/heart-failure-more-likely-in-cad-patients-who-are-depressed/2009-04-13T23:26:41+00:00monthlyhttp://cardiobrief.org/2009/04/13/merck-and-cardiome-to-collaborate-on-oral-vernakalant/2009-04-13T14:36:21+00:00monthlyhttp://cardiobrief.org/2009/04/09/nejm-lancet-stop-the-soda-madness/2009-04-09T16:14:36+00:00monthlyhttp://cardiobrief.org/2009/04/08/brown-adipose-tissue-jack-sprat-had-it-his-wife-didnt/2009-04-08T21:05:02+00:00monthlyhttp://cardiobrief.org/2009/04/07/psaty-raises-more-questions-about-conflict-of-interest-in-jama-commentary/2009-04-08T19:26:33+00:00monthlyhttp://cardiobrief.org/2009/04/08/prasugrel-makes-worldwide-debut-in-united-kingdom/2009-04-08T14:41:37+00:00monthlyhttp://cardiobrief.org/2009/04/07/presto-chango-hf-action-shows-benefits-of-exercise-in-heart-failure/2009-04-07T18:25:39+00:00monthlyhttp://cardiobrief.org/2009/04/07/ny-times-difficult-decisions-about-sprint-fidelis-leads/2009-04-07T14:36:50+00:00monthlyhttp://cardiobrief.org/2009/04/06/uh-oh-cigarette-smoking-found-to-enhance-clopidogrel-clinical-benefits/2009-04-06T22:57:46+00:00monthlyhttp://cardiobrief.org/2009/04/03/fda-bungles-posting-of-seroquel-briefing-documents-and-raises-concerns-about-cv-effects/2009-04-06T14:56:03+00:00monthlyhttp://cardiobrief.org/2009/04/03/new-study-provides-best-proof-yet-of-myocardial-regeneration/2009-04-03T14:09:40+00:00monthlyhttp://cardiobrief.org/2009/04/02/fda-panel-gives-split-decision-to-diabetes-drug-liraglutide/2009-04-02T23:38:21+00:00monthlyhttp://cardiobrief.org/2009/04/02/yusuf-kaul-launch-rocket-attack-at-jupiter-ridker-responds/2009-04-05T07:36:00+00:00monthlyhttp://cardiobrief.org/2009/04/01/fda-advisory-panel-saxagliptin-passes-cardiac-stress-test/2009-04-02T03:30:07+00:00monthlyhttp://cardiobrief.org/2009/04/01/article-explores-complexity-of-pci-public-reporting-in-massachusett/2009-04-01T18:52:18+00:00monthlyhttp://cardiobrief.org/2009/03/31/jama-writers-call-for-medical-groups-to-sever-financial-ties-to-industry/2009-04-01T17:21:43+00:00monthlyhttp://cardiobrief.org/2009/04/02/too-much-grapefruit-nearly-causes-loss-of-leg/2009-04-01T15:14:15+00:00monthlyhttp://cardiobrief.org/2009/03/31/active-a-clopidogrel-aspirin-better-than-aspirin-alone-in-af/2009-03-31T14:03:43+00:00monthlyhttp://cardiobrief.org/2009/03/30/aurora-no-new-dawn-for-hemodialysis-patients-taking-rosuvastatin/2009-03-30T16:36:13+00:00monthlyhttp://cardiobrief.org/2009/03/30/tips-promising-phase-ii-trial-for-polypill/2009-03-30T16:31:32+00:00monthlyhttp://cardiobrief.org/2009/03/30/study-shows-proof-of-concept-of-renal-denervation-for-resistant-hypertension/2009-03-30T15:26:30+00:00monthlyhttp://cardiobrief.org/2009/03/29/more-jupiter-crp-and-ldl-equally-influence-outcome/2009-03-30T13:38:28+00:00monthlyhttp://cardiobrief.org/2009/03/30/early-acs-no-benefit-and-increased-bleeding-with-early-eptifibatide/2009-03-30T13:34:32+00:00monthlyhttp://cardiobrief.org/2009/03/30/arena-reports-postive-phase-3-results-for-locaserin/2009-03-30T13:31:37+00:00monthlyhttp://cardiobrief.org/2009/03/28/ncdr-registry-supports-des-over-bms-in-elderly-patients/2009-03-29T19:06:34+00:00monthlyhttp://cardiobrief.org/2009/03/29/fix-hf-5-trial-misses-endpoint-but-hope-remains-for-cardiac-contractility-modulation-in-hf/2009-03-29T14:42:19+00:00monthlyhttp://cardiobrief.org/2009/03/29/stich-svr-provides-no-added-benefit-to-cabg/2009-03-29T13:53:14+00:00monthlyhttp://cardiobrief.org/2009/03/29/more-jupiter-rosuvastatin-also-prevents-vte/2009-03-29T01:24:15+00:00monthlyhttp://cardiobrief.org/2009/03/29/pre-relax-ahf-phase-ii-study-suggests-relaxin-may-be-beneficial-in-hf/2009-03-29T01:19:30+00:00monthlyhttp://cardiobrief.org/2009/03/28/protect-af-new-device-may-offer-alternative-to-warfarin-for-af-patients/2009-03-29T00:37:06+00:00monthlyhttp://cardiobrief.org/2009/03/28/syntax-pci-begins-to-gain-over-cabg-in-new-analysis/2009-03-29T00:35:13+00:00monthlyhttp://cardiobrief.org/2009/03/28/jama-editors-now-subject-of-ama-investigation/2009-03-28T23:21:28+00:00monthlyhttp://cardiobrief.org/2009/03/26/boston-scientific-issues-product-advisories-on-new-icds/2009-03-27T00:05:13+00:00monthlyhttp://cardiobrief.org/2009/03/26/acc-and-aha-release-updated-heart-failure-guidelines/2009-03-26T17:45:10+00:00monthlyhttp://cardiobrief.org/2009/03/26/remembering-philip-poole-wilson/2009-03-26T16:50:19+00:00monthlyhttp://cardiobrief.org/2009/03/27/acc-in-orlando-march-madness-starts-saturday/2009-03-26T14:32:05+00:00monthlyhttp://cardiobrief.org/2009/03/26/mehmet-oz-wants-to-tell-you-your-real-age/2009-03-26T14:06:40+00:00monthlyhttp://cardiobrief.org/2009/03/25/case-reports-link-stress-cardiomyopathy-to-catecholamines-and-beta-agonists/2009-03-24T16:52:02+00:00monthlyhttp://cardiobrief.org/2009/03/22/jama-editors-take-strong-stance-against-conflict-of-interest-and-free-speech/2009-07-10T13:35:23+00:00monthlyhttp://cardiobrief.org/2009/03/24/nice-sugar-intensive-glucose-control-in-icu-found-harmful/2009-03-24T11:38:52+00:00monthlyhttp://cardiobrief.org/2009/03/21/a-shape-board-member-responds-to-critical-editorial/2009-05-13T00:54:17+00:00monthlyhttp://cardiobrief.org/2009/03/17/editorial-shape-is-skating-on-thin-ice/2009-03-21T04:05:11+00:00monthlyhttp://cardiobrief.org/2009/03/25/nejm-letter-warns-about-icd-shocks-caused-by-current-leaks/2009-03-20T18:10:03+00:00monthlyhttp://cardiobrief.org/2009/03/20/fda-panel-turns-down-therox-aqueous-oxygen-system-in-9-5-vote/2009-03-20T17:25:48+00:00monthlyhttp://cardiobrief.org/2009/03/18/young-blacks-more-likely-to-develop-heart-failure/2009-03-20T17:08:50+00:00monthlyhttp://cardiobrief.org/2009/03/19/fda-panel-votes-15-2-in-favor-of-rivaroxaban/2009-03-20T17:07:54+00:00monthlyhttp://cardiobrief.org/2009/03/24/lamp2-mutation-causes-severe-cardiomyopathy-in-young-patients/2009-03-20T15:51:23+00:00monthlyhttp://cardiobrief.org/2009/03/23/very-low-ldl-normal-bp-good-ivus-outcome/2009-07-08T13:49:08+00:00monthlyhttp://cardiobrief.org/2009/03/19/meta-analysis-cabg-beats-pci-in-diabetics-and-elderly/2009-03-19T23:43:04+00:00monthlyhttp://cardiobrief.org/2009/03/18/dronedarone-gets-cautious-nod-from-fda-advisory-panel/2009-03-19T00:29:42+00:00monthlyhttp://cardiobrief.org/2009/03/18/cardiovascular-research-does-pharma-see-a-future/2010-08-18T23:51:09+00:00monthlyhttp://cardiobrief.org/2009/03/18/have-the-results-of-the-aurora-study-been-leaked/2009-03-18T15:57:19+00:00monthlyhttp://cardiobrief.org/2009/03/17/rivaroxaban-may-face-tough-questions-about-bleeding-risk/2009-03-17T20:31:06+00:00monthlyhttp://cardiobrief.org/2009/03/16/fda-reviewers-give-green-light-for-dronedarone/2009-03-16T14:56:16+00:00monthlyhttp://cardiobrief.org/2009/03/14/statins-may-help-fight-severe-asthma-attacks/2009-04-29T22:43:00+00:00monthlyhttp://cardiobrief.org/2009/03/17/no-surprise-acat-inhibitor-fails-again/2009-03-14T14:15:57+00:00monthlyhttp://cardiobrief.org/2009/03/16/exercise-dont-stop-or-you-just-might-drop/2009-03-14T13:46:24+00:00monthlyhttp://cardiobrief.org/2009/03/16/normal-abi-isnt-really-normal/2009-03-14T13:20:17+00:00monthlyhttp://cardiobrief.org/2009/03/13/number-of-deaths-linked-to-sprint-fidelis-leads-rises-to-13/2009-03-13T23:13:22+00:00monthlyhttp://cardiobrief.org/2009/03/13/demolition-derby-jama-bmj-and-wall-street-journal-health-blog/2009-03-14T15:58:55+00:00monthlyhttp://cardiobrief.org/2009/03/13/nyc-contd-rose-gets-a-raise-at-mt-sinai/2009-03-13T14:48:49+00:00monthlyhttp://cardiobrief.org/2009/02/24/cardiology-mt-sinais-samin-sharma-tops-columbias-moses/2009-03-13T13:59:44+00:00monthlyhttp://cardiobrief.org/2009/03/12/phase-2-data-on-scherings-tra-published-in-lancet/2009-03-12T23:37:45+00:00monthlyhttp://cardiobrief.org/2009/03/12/gilead-topping-astellas-to-acquire-cv-therapeutics/2009-03-12T13:21:42+00:00monthlyhttp://cardiobrief.org/2009/03/11/new-test-can-diagnose-arvc-2/2009-03-11T21:13:57+00:00monthlyhttp://cardiobrief.org/2009/03/10/dronedarone-post-mi-hyperoxygenation-system-face-fda-panels-next-week/2009-03-11T19:20:05+00:00monthlyhttp://cardiobrief.org/2009/03/12/europe-losing-battle-against-heart-disease/2009-03-11T19:00:14+00:00monthlyhttp://cardiobrief.org/2009/03/12/pci-no-impact-on-mortality-or-mi-no-surprise/2009-03-11T18:27:56+00:00monthlyhttp://cardiobrief.org/2009/03/12/absorb-this-bioabsorbable-stent-remains-promising-at-2-years/2009-03-11T18:08:20+00:00monthlyhttp://cardiobrief.org/2009/03/11/sprint-fidelis-judge-wont-step-down-from-case/2009-03-11T17:37:14+00:00monthlyhttp://cardiobrief.org/2009/03/10/ahas-robertson-legislation-is-a-very-blunt-instrument/2009-03-10T18:15:56+00:00monthlyhttp://cardiobrief.org/2009/03/10/fda-posts-transcript-and-minutes-of-prasugrel-hearing/2009-03-10T17:09:27+00:00monthlyhttp://cardiobrief.org/2009/03/09/aha-denies-it-supports-texas-shape-legislation-2/2009-03-10T01:00:51+00:00monthlyhttp://cardiobrief.org/2009/03/09/depression-and-antidepressants-tied-to-cardiac-events/2009-03-09T21:21:55+00:00monthlyhttp://cardiobrief.org/2009/03/09/angry-men-and-bad-hearts/2009-03-09T21:20:39+00:00monthlyhttp://cardiobrief.org/2009/03/09/jupiter-usa-65-million-adults-could-benefit-from-statins/2009-03-09T21:19:26+00:00monthlyhttp://cardiobrief.org/2009/03/09/texas-legislature-to-consider-shape-bill-to-require-reimbursement-for-mi-screening/2009-03-10T10:27:53+00:00monthlyhttp://cardiobrief.org/2009/03/08/us-investigates-medtronics-marketing-of-ablation-devices/2009-03-09T00:26:29+00:00monthlyhttp://cardiobrief.org/2009/03/06/treating-flu-with-oseltamivir-reduces-cv-events-military-study-finds/2009-03-06T16:54:06+00:00monthlyhttp://cardiobrief.org/2009/03/06/generic-simvastatin-cost-effective-in-wider-population-than-current-guidelines-indicate/2009-03-06T16:29:34+00:00monthlyhttp://cardiobrief.org/2009/03/05/philip-poole-wilson-leading-british-cardiologist-dies-suddenly/2009-03-05T15:13:00+00:00monthlyhttp://cardiobrief.org/2009/03/04/mtwa-may-help-low-risk-patients-avoid-icd-implantation/2009-03-04T16:55:27+00:00monthlyhttp://cardiobrief.org/2009/03/03/samin-sharma-reveals-the-secret-behind-1500-cases-and-26-million-per-year/2009-03-04T00:53:51+00:00monthlyhttp://cardiobrief.org/2009/03/02/fda-approves-new-magnetically-steered-irrigated-tip-rf-ablation-catheter/2009-03-02T21:59:22+00:00monthlyhttp://cardiobrief.org/2009/03/02/public-reporting-of-pci-outcomes-unintended-consequences/2009-03-02T18:08:23+00:00monthlyhttp://cardiobrief.org/2009/02/27/ny-times-why-is-the-icd-registry-languishing/2009-02-27T23:10:42+00:00monthlyhttp://cardiobrief.org/2009/02/27/flap-over-prasugrel-advisory-committee-leads-to-2-congressional-inquiries/2009-02-27T16:06:42+00:00monthlyhttp://cardiobrief.org/2009/02/26/speaking-of-prasugrel-triton-timi-38-stemi-substudy-published-in-lancet/2009-02-27T15:29:05+00:00monthlyhttp://cardiobrief.org/2009/02/27/astellas-launches-hostile-takeover-for-cv-therapeutics/2009-02-27T14:42:30+00:00monthlyhttp://cardiobrief.org/2009/02/26/transcript-of-fda-february-23-news-conference-on-prasugrel-advisory-panel/2009-02-26T16:38:13+00:00monthlyhttp://cardiobrief.org/2009/02/25/califf-now-reportedly-out-of-running-for-fda-commissioner/2009-02-25T21:51:30+00:00monthlyhttp://cardiobrief.org/2009/02/26/679/2009-02-25T17:37:22+00:00monthlyhttp://cardiobrief.org/2009/02/25/meta-analysis-lowering-bp-in-dialysis-patients-reduces-cv-events-and-deaths/2009-02-25T15:37:59+00:00monthlyhttp://cardiobrief.org/2009/02/24/sprint-fiedlis-leads-is-the-risk-greater-than-feared/2009-02-25T15:15:31+00:00monthlyhttp://cardiobrief.org/2009/02/23/anger-increases-risk-for-sudden-death/2009-02-25T15:14:12+00:00monthlyhttp://cardiobrief.org/2009/02/24/accaha-guidelines-not-enough-evidence/2009-02-24T16:59:39+00:00monthlyhttp://cardiobrief.org/2009/02/25/no-difference-in-weight-loss-after-2-years-in-weight-loss-diets/2009-02-23T18:09:49+00:00monthlyhttp://cardiobrief.org/2009/02/23/medtronic-gobbles-up-2-aortic-valve-companies/2009-02-23T15:53:17+00:00monthlyhttp://cardiobrief.org/2009/02/23/prasugrel-gains-european-approval/2009-02-23T15:14:43+00:00monthlyhttp://cardiobrief.org/2009/02/23/jeffrey-moses-ranks-8-on-chronicles-salary-list/2009-02-23T21:27:12+00:00monthlyhttp://cardiobrief.org/2009/02/20/jupiter-substudy-stroke-cut-in-half-by-rosuvastatin/2009-02-20T20:23:24+00:00monthlyhttp://cardiobrief.org/2009/02/19/the-uninvited-part-2-fda-offers-more-detailed-explanation-for-kauls-absence-on-prasugrel-committee/2009-02-20T20:08:54+00:00monthlyhttp://cardiobrief.org/2009/02/19/us-justice-dept-joins-lawsuit-against-sciosjj/2009-03-02T02:28:49+00:00monthlyhttp://cardiobrief.org/2009/02/19/599/2009-02-20T03:33:28+00:00monthlyhttp://cardiobrief.org/2009/02/19/questions-raised-over-globalization-of-clinical-research/2009-02-19T15:04:38+00:00monthlyhttp://cardiobrief.org/2009/02/18/syntax-published-in-nejm/2009-02-18T20:05:52+00:00monthlyhttp://cardiobrief.org/2009/02/18/oat-no-improved-quality-of-life-found-for-late-opening-of-occluded-arteries/2009-02-18T19:36:48+00:00monthlyhttp://cardiobrief.org/2009/02/17/new-analysis-casts-doubt-on-hdl-as-target-for-therapy/2009-02-17T18:59:39+00:00monthlyhttp://cardiobrief.org/2009/02/13/fda-advisory-committee-to-consider-dronedarone-in-march/2009-02-14T15:59:40+00:00monthlyhttp://cardiobrief.org/2009/02/14/salt-ii-letter-writers-react-to-aldermans-ny-times-op-ed-piece/2009-02-14T15:58:24+00:00monthlyhttp://cardiobrief.org/2009/02/13/stent-wars-abbott-wins-and-medtronic-loses/2009-02-14T01:18:03+00:00monthlyhttp://cardiobrief.org/2009/02/13/heartwire-story-provides-most-detailed-account-yet-of-prasugrel-hearing/2009-02-14T01:13:08+00:00monthlyhttp://cardiobrief.org/2009/02/18/pharmacogenetics-a-better-path-to-warfarin-dosing/2009-02-20T07:01:39+00:00monthlyhttp://cardiobrief.org/2009/02/11/athena-published-in-nejm-dronedarone-benefits-af-patients/2009-02-13T13:48:16+00:00monthlyhttp://cardiobrief.org/2009/02/12/judge-who-ruled-in-favor-of-medtronic-failed-to-disclose-family-link-to-company/2009-02-13T04:00:03+00:00monthlyhttp://cardiobrief.org/2009/02/16/elderly-in-cardiogenic-shock-benefit-from-early-pci/2009-02-12T18:47:58+00:00monthlyhttp://cardiobrief.org/2009/02/12/registry-sheds-light-on-takotsubo-cardiomyopathy/2009-02-12T17:24:48+00:00monthlyhttp://cardiobrief.org/2009/02/12/after-fame-new-study-offers-clues-to-utility-of-ffr/2009-02-12T17:12:48+00:00monthlyhttp://cardiobrief.org/2009/02/11/fda-provides-explanation-for-sanjay-kauls-absence/2009-02-12T00:33:20+00:00monthlyhttp://cardiobrief.org/2009/02/11/prasugrel-now-the-real-work-starts/2009-02-12T00:32:24+00:00monthlyhttp://cardiobrief.org/2009/02/11/contrast-echo-found-useful-in-technically-difficult-cases/2009-02-11T15:02:58+00:00monthlyhttp://cardiobrief.org/2009/02/10/spirit-iii-trial-published/2009-02-11T00:44:22+00:00monthlyhttp://cardiobrief.org/2009/02/15/researchers-identify-first-common-genes-variants-that-regulate-blood-pressure/2009-02-10T19:14:20+00:00monthlyhttp://cardiobrief.org/2009/02/10/list-of-acc-2009-late-breakers-published/2009-02-10T17:08:47+00:00monthlyhttp://cardiobrief.org/2009/02/10/david-sabiston-jr-pioneering-surgeon-dead-at-84/2009-02-10T15:10:23+00:00monthlyhttp://cardiobrief.org/2009/02/09/expensive-urine-multivitamins-have-no-effect-on-major-endpoints/2009-02-16T19:26:58+00:00monthlyhttp://cardiobrief.org/2009/02/09/study-finds-lower-risk-of-death-for-primary-prevention-use-of-statins/2009-02-09T17:18:06+00:00monthlyhttp://cardiobrief.org/2009/02/09/mass-general-under-scrutiny-for-high-mortality-rate-in-cath-lab/2009-02-09T17:09:13+00:00monthlyhttp://cardiobrief.org/2009/02/09/editorial-prasugrel-and-fda-incompetence/2009-02-11T21:15:39+00:00monthlyhttp://cardiobrief.org/2009/02/06/fda-approves-2-ablation-catheters-for-af/2009-02-06T21:55:39+00:00monthlyhttp://cardiobrief.org/2009/02/06/do-beta-blockers-inhibit-the-anti-inflammatory-effect-of-statins/2009-02-06T15:56:48+00:00monthlyhttp://cardiobrief.org/2009/02/06/alderman-questions-nyc-efforts-to-cut-salt-in-ny-times-opinion-piece/2009-02-06T15:36:21+00:00monthlyhttp://cardiobrief.org/2009/02/05/early-study-finds-anacetrapib-safe-and-effective/2009-02-06T00:53:27+00:00monthlyhttp://cardiobrief.org/2009/02/05/gordon-tomaselli-named-director-of-cardiology-at-johns-hopkins/2009-02-06T00:35:05+00:00monthlyhttp://cardiobrief.org/2009/02/05/sir-james-black-pioneer-of-propranolol-decries-state-of-pharma/2009-02-06T00:21:18+00:00monthlyhttp://cardiobrief.org/2009/02/09/pci-for-mi-experienced-hospitals-and-physicians-are-best/2009-02-05T17:38:04+00:00monthlyhttp://cardiobrief.org/2009/02/05/new-des-studies-add-new-understanding-about-clopidogrel-duration-lad-usage-and-isr/2009-02-05T17:13:58+00:00monthlyhttp://cardiobrief.org/2009/02/04/outspoken-critic-prasugrel-hearing-was-a-family-picnic/2009-02-05T15:40:48+00:00monthlyhttp://cardiobrief.org/2009/02/03/fda-panel-unanimously-recommends-approval-of-prasugrel/2009-02-04T04:29:55+00:00monthlyhttp://cardiobrief.org/2009/02/03/radiation-in-cardiology-comes-under-increased-scrutiny/2009-02-03T21:32:23+00:00monthlyhttp://cardiobrief.org/2009/02/03/califf-reportedly-still-in-running-to-be-fda-commissioner/2009-02-03T20:11:07+00:00monthlyhttp://cardiobrief.org/2009/02/08/5-new-studies-shed-new-light-on-the-genetics-of-mi/2009-02-03T19:03:26+00:00monthlyhttp://cardiobrief.org/2009/02/03/t-wave-alternans-may-help-identify-some-patients-who-dont-need-an-icd/2009-02-05T01:42:03+00:00monthlyhttp://cardiobrief.org/2009/02/02/atorvastatin-finds-its-own-planetoid/2009-02-03T14:30:38+00:00monthlyhttp://cardiobrief.org/2009/02/02/sanjay-kaul-removed-from-prasugrels-fda-advisory-panel/2009-02-02T21:41:38+00:00monthlyhttp://cardiobrief.org/2009/02/02/get-your-original-unscrubbed-fda-prasugrel-review-document-right-here/2009-02-11T14:12:56+00:00monthlyhttp://cardiobrief.org/2009/01/30/more-on-prasugrel-what-the-fda-doesnt-want-you-to-know/2009-02-02T18:47:08+00:00monthlyhttp://cardiobrief.org/2009/01/30/prasugrel-outlook-appears-brighter/2009-02-02T16:28:45+00:00monthlyhttp://cardiobrief.org/2009/01/29/lancet-editorial-orlistat-should-not-be-available-over-the-counter/2009-01-30T17:20:56+00:00monthlyhttp://cardiobrief.org/2009/01/29/wikidoc-news-ppis-may-interfere-with-clopidogrel-lead-to-repeat-mi/2009-01-30T01:16:10+00:00monthlyhttp://cardiobrief.org/2009/01/29/urine-test-for-cad-in-the-future/2009-01-29T19:17:20+00:00monthlyhttp://cardiobrief.org/2009/01/28/generic-metoprolol-succinate-shortage-causing-problems/2009-08-11T22:28:57+00:00monthlyhttp://cardiobrief.org/2009/01/28/spect-mpi-may-be-useful-in-new-onset-hf/2009-01-28T19:04:52+00:00monthlyhttp://cardiobrief.org/2009/01/27/time-chf-bnp-guided-therapy-misses-the-boat/2009-01-28T16:24:14+00:00monthlyhttp://cardiobrief.org/2009/01/28/fda-warning-dietary-supplement-contains-sibutramine/2009-01-28T16:21:29+00:00monthlyhttp://cardiobrief.org/2009/01/28/cv-therapeutics-rejects-buyout-offer-from-astellas-pharma/2009-01-28T14:41:17+00:00monthlyhttp://cardiobrief.org/2009/01/27/thrombectomy-found-useful-adjunct-in-primary-pci/2009-01-27T19:42:39+00:00monthlyhttp://cardiobrief.org/2009/01/27/uric-acid-and-insulin-levels-linked-to-risk-of-hypertension/2009-01-27T15:40:59+00:00monthlyhttp://cardiobrief.org/2009/01/26/combination-of-aerobic-and-strength-exercise-found-best-for-elderly-obese-adults/2009-01-27T04:58:02+00:00monthlyhttp://cardiobrief.org/2009/01/26/danish-researchers-recommend-avoiding-nsaids-in-hf/2009-01-27T04:56:34+00:00monthlyhttp://cardiobrief.org/2009/01/26/krumholz-weighs-in-on-nsaids-in-chf/2009-01-27T04:33:06+00:00monthlyhttp://cardiobrief.org/2009/01/26/fda-announces-ongoing-safety-review-of-clopidogrel/2009-01-26T20:30:25+00:00monthlyhttp://cardiobrief.org/2009/01/26/innovative-stent-company-seeks-emergency-intervention/2009-01-26T15:27:48+00:00monthlyhttp://cardiobrief.org/2009/01/23/stun-guns-study-raises-questions-about-safety/2009-01-23T17:27:53+00:00monthlyhttp://cardiobrief.org/2009/01/23/drug-eluting-stents-are-they-cost-effective/2009-01-23T17:14:07+00:00monthlyhttp://cardiobrief.org/2009/01/22/pooled-analysis-shows-ezetimibe-enhances-crp-reduction/2009-01-22T17:03:32+00:00monthlyhttp://cardiobrief.org/2009/01/22/pascal-goldschmidt-cant-stop-running/2009-01-22T15:12:19+00:00monthlyhttp://cardiobrief.org/2009/01/21/abbotts-xience-v-claims-bragging-rights-as-top-selling-stent/2009-01-21T20:58:49+00:00monthlyhttp://cardiobrief.org/2009/01/21/how-does-the-media-report-on-cardiovascular-genetics/2009-01-21T15:55:22+00:00monthlyhttp://cardiobrief.org/2009/01/21/nissen-gives-advice-to-new-president/2009-01-21T15:23:14+00:00monthlyhttp://cardiobrief.org/2009/01/19/califf-reportedly-still-in-running-for-fda-commssioner/2009-01-20T00:21:42+00:00monthlyhttp://cardiobrief.org/2009/01/20/diastolic-dysfunction-associated-with-reduced-exercise-capacity/2009-01-16T23:40:03+00:00monthlyhttp://cardiobrief.org/2009/01/15/acc-preannouncement-season-begins-with-small-companys-press-release/2009-01-16T18:32:08+00:00monthlyhttp://cardiobrief.org/2009/01/14/fame-pubbed-in-nejm-is-ffr-ready-to-step-into-the-spotlight/2009-01-16T02:39:15+00:00monthlyhttp://cardiobrief.org/2009/01/13/experts-remain-convinced-of-benefits-despite-negative-lifestyle-trials/2009-01-14T20:48:53+00:00monthlyhttp://cardiobrief.org/2009/01/14/senate-investigation-revealing-new-details-in-avandia-case-wsj-reports/2009-01-14T20:48:03+00:00monthlyhttp://cardiobrief.org/2009/01/14/more-headaches-for-pfo-closure-devices/2009-01-14T20:47:37+00:00monthlyhttp://cardiobrief.org/2009/01/13/exercise-found-beneficial-in-pad-patients/2009-01-14T04:37:37+00:00monthlyhttp://cardiobrief.org/2009/01/18/gene-variant-found-to-increase-risk-of-cardiomyopathy-seven-fold-in-south-asians/2009-01-13T20:20:45+00:00monthlyhttp://cardiobrief.org/2009/01/14/newer-antipsychotic-agents-also-cause-scd/2009-01-13T17:40:03+00:00monthlyhttp://cardiobrief.org/2009/01/08/after-a-year-long-review-fda-finds-nothing-new-about-vytorim/2009-01-12T23:37:58+00:00monthlyhttp://cardiobrief.org/2009/01/12/medtronic-acquires-another-af-ablation-company/2009-01-12T16:23:28+00:00monthlyhttp://cardiobrief.org/2009/01/08/boston-scientific-acquires-company-with-biodegradable-polymer-des-technology/2009-01-08T18:33:55+00:00monthlyhttp://cardiobrief.org/2009/01/08/hiv-infected-cardiothoracic-surgeon/2009-01-08T17:53:04+00:00monthlyhttp://cardiobrief.org/2009/01/08/45-years-in-the-business-bill-roberts-part-2/2009-01-08T17:12:03+00:00monthlyhttp://cardiobrief.org/2009/01/08/too-many-cardiology-journals-bill-roberts-ajc-editor-speaks-out/2009-01-08T15:57:42+00:00monthlyhttp://cardiobrief.org/2009/01/06/court-dismisses-complaint-against-medtronic-over-fidelis-leads/2009-01-06T18:46:25+00:00monthlyhttp://cardiobrief.org/2009/01/06/has-courage-been-vindicated/2009-01-06T18:34:44+00:00monthlyhttp://cardiobrief.org/2009/01/05/npy-gene-linked-to-early-cv-disease/2009-01-05T19:41:02+00:00monthlyhttp://cardiobrief.org/daily1.02010-09-09T23:48:36+00:00